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Abstract
Background
The majority of patients requiring mechanical ventilation are over the age of 65 and
advanced age is known to increase the severity of ventilator-induced lung injury (VILI)
and mortality. However, the mechanisms which predispose aging ventilator patients to
increased mortality rates are not fully understood.
Pulmonary edema is a hallmark of VILI and the severity of edema increases with
age. Ventilation with conservative fluid management decreases mortality rates in acute
respiratory distress (ARDS) patients, but has not been investigated in VILI. We
hypothesized that age-associated increases in pulmonary edema promote age-related
increases in ventilator-associated mortality. Endoplasmic reticulum (ER) stress can
disrupt cellular functions and plays a key role in many disease states. The severity of
ER stress also increases with age. We hypothesized that age-associated increases in
ER stress also increase in the severity of VILI.
Finally, serum Vitamin C (VitC) levels also decrease with age. VitC treatments
have been shown to decrease mortality rates in murine models of ARDS by and
attenuate pulmonary edema. We hypothesize that VitC treatments will attenuate
ventilator induced pulmonary edema in our aged murine subjects.
Methods
Mechanical Ventilation: Young and old mice were mechanically ventilated with either
high tidal volume (HVT) or low tidal volume (LVT) for with either liberal or conservative
fluid support. One group received VitC treatment prior to ventilation.
xii

Cell Stretch: Alveolar epithelial cells (ATIIs) from young and old mice were harvested,
cultured, and mechanically stretched. Treatment groups received ER stress inhibitor 4PBA.
Results
Both advanced age and HVT ventilation significantly increased inflammation, injury, and
decreased survival rates. Conservative fluid support significantly diminished pulmonary
edema decreased mortality rates. VitC treatments significantly decreased pulmonary
edema and improved pulmonary mechanics. Mechanical stretch promoted ER Stress
and upregulated proinflammatory gene expression and secretion in aged ATIIs. ER
stress inhibition attenuated all of these effects.
Conclusion
Conservative fluid management alone attenuated age-associated increases in
ventilator-associated mortality. VitC treatments decreased pulmonary edema and
partially restore pulmonary mechanics in old mice ventilated with HVT. ER stress
inhibition decreased stretch induced proinflammatory gene expression and protein
secretion in aged mechanically stretched ATII cells.

xiii

CHAPTER 1
INTRODUCTION

1.1.0 Lung Anatomy and Physiology
In humans the chief function of the lungs is to facilitate the exchange of carbon dioxide
and oxygen between our blood stream and the atmosphere. In addition to respiration
the lungs perform numerous other important biological functions which include providing
the expiration of air needed for phonation, extra buoyancy when we are immersed in
water, a supplemental method of thermoregulation, and the lungs mucosal layer and
leukocytes act as an important second line of defense against inhaled infectious agents
and other harmful environmental factors1,2.

1.1.1 Generations of the Lung
The physical pathway through which air moves is known as the respiratory tract. The
respiratory tract begins as a single airway but as it moves distally it divides. Every
division is roughly a bifurcation and each is ascendingly enumerated as generation
(figure 1).

1

3

Figure 1: Diagram of the divisions of the respiratory tract. Reprinted from McNulty et al .

The first 16 generations (divisions 0 through 15) of the respiratory tract are called
the conduction zone and include the nose, pharynx, larynx, trachea, bronchi,
bronchioles, and terminal bronchioles. Because each generation of divisions roughly
doubles the number of pathways in the respiratory tract the final generation of the
conduction zone has approximately 32,270 pathways or roughly 2^15. The primary
function of the conducting zone is to act as a passageway through which air is able to
2

reach the rest of the respiratory tract. In addition the conduction zone filters, heats, and
humidifies the inhaled air all of which aid in respiration. The conduction zone is also the
site of phonation1,4.
Additionally, the conduction zone acts as the body's first line of defense against
inhaled pathogens and harmful environmental factors. The epithelium of the conducting
airways contains goblet cells which secrete high molecular weight mucus glycoproteins
which entrap inhaled irritants, particles and micro-organisms. These same epithelium
are also lined with motile cilia which function to move the entrapped material up and out
of the respiratory tract1,5–7

Figure 2: Respiratory Bronchioles transition from a terminal bronchiole, to respiratory bronchioles, to
8
alveolar ducts, which terminate in alveolar sacs and individual alveoli. Reprinted from Kerr et al .

The remaining nine generations (divisions 16 through 24) of the respiratory tract
are known as the respiratory zone and contain the respiratory bronchioles, alveolar
ducts, alveolar sacs, and the individual alveoli (figure 2). As its name suggest the
respiratory zone is the region in which all of the respiration takes place. The functional
3

biological units of respiration are small space filled fluid lined sacs called alveoli (figure
3) through which carbon dioxide and oxygen are exchanged with the bloodstream 1.

Figure 3: Alveolus Diagram. Reprinted from public domain

9

As the bronchioles go through successive generations of division eventually
around their 6th generation (the 17th generation of the respiratory tract overall) they
begin to express individual alveoli as outgrowths. With each successive generation, the
number of individual alveolar outgrowths increases.
This continues as the respiratory bronchioles eventually divide into the alveolar
ducts which are heavily lined with alveoli. Each alveolar duct terminates with 2-3 large
clusters of alveoli called an alveolar sac. The terminal ends of the alveolar ducts occur

4

at the 23rd division which means that there are roughly 16.8 - 25.2 million alveolar sacs
in the adult lungs.
Each sac contains roughly 20 alveoli which mean that there are roughly 350-500
million alveoli in each pair of adult human lungs. The alveolar sacs contain the largest
concentration of alveoli in the body. The individual alveoli on the respiratory bronchioles
and the alveolar ducts are responsible for roughly 10% of the gas exchanged during
respiration and the alveoli contained in alveolar sacs are responsible for the remaining
90%1,5,10.
1.1.2 Alveolar Structure and Function
In total the alveolar walls, or interalveolar septa, account for 99% of the interior surface
area of the lungs which in adult humans is about 100 to 150 square meters. The alveoli
share these septa among neighboring alveoli which makes it impossible to make an
exact distinction between the individual alveoli. When a 2D section of lung parenchyma
is viewed it closely resembles dense foam with the major difference being that the
alveolar sacs eventually open to alveolar ducts which interconnect and lead back up the
respiratory tract1,2,5. The alveoli have two kinds of openings in addition to the main
opening to the alveolar duct.
The first type of openings are called pores of Kohn and serve to interconnect
neighboring alveoli. The second type of openings are called canals of Lambert and
connect the alveoli to the terminal respiratory bronchioles. Both of these openings have
the same basic function which is that they allow air to pass collaterally between the
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alveoli and bronchioles. This creates an interdependence in the alveolar air pressure
which helps to stabilize them and helps air to reach underinflated alveolus 1
1.1.3 Alveolar Epithelial Cells
The alveolar septa are covered with two morphologically distinct types of pneumocyte
cells.

Figure 4: Diagram of the alveolar epithelium. Reprinted from Antranik et al .
14

ATI pneumocytes (ATIs) are squamous epithelial cells which means that they are flat,
stretched out, and create a tile like cell layer. They cover both the inner and outer

surface of the alveolar septa (figure 4). ATI cells are also relatively large (diameter of ∼
50 to 100 μm and volume of ∼ 2,000 to 3,000 μm3). ATII pneumocytes are cuboidal

epithelial cells. They exist only on the interior surface of the alveolar septa and protrude
into the interior space of the alveolar sacs. They are relatively small compared to the
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ATI cells (diameter ∼ 10 μm and volume of ∼ 450 to 900 μm3). Even though ATI cells
comprise only 8% of the cells found in the alveolar region, because of their larger size
and their extremely stretched flattened arrangement they cover 95% of the alveolar
surface, the rest being covered by the ATII cells7,15.
It has long been assumed that since ATI cells form the surface across which
essentially all of the gas is exchanged during respiration that they have significant
functionality with regards to facilitating this process. However, the physiological role of
ATI cells in respiration is still yet to be fully elucidated. Despite this shortcoming our
understanding of their role in innate host defense and in alveolar fluid clearance has
developed considerably in the recent past. The Na+ gradient that drives fluid absorption
across the alveolar epithelial barrier is created by active transport through the Na-KATPase pump, the 1a and 1b subunits of which are the most common Na pump
subunits in alveolar epithelial cells. In one study a cell specific deletion of the 1b
subunits in ATI’s created a significant decrease in alveolar fluid clearance 16. However,
this knockout did not lead to increased pulmonary edema in either hyperoxia induced or
ventilator induced lung injury models relative to similarly injured wild type controls.
Thus while ATIs involvement in alveolar fluid clearance is clear their exact role is
yet to be fully elucidated. Additionally, it has recently been discovered that the
inflammatory response of ATI cells to inflammation and injury is more acute than that of
ATIIs17. In one study, relative to similarly cultured ATIIs, isolated ATI’s were shown to
exhibit both a higher level of inflammatory gene expression in control groups, when
treated with LPS, when cocultured with alveolar macrophages, and when cultured with
treated media from LPS treated macrophages18.
7

It is also known that ATI cells are generally unable to proliferate 15 which leads to
one of the two primary functions of ATIIs. ATII cells are responsible for mediating all
primary replenishment of injured or dead alveolar epithelial cells. When either ATI or
ATII cells die and are sloughed off they leave a nude section of the basement
membrane. When this occurs resident ATII cells divide and repopulate the area. They
then either remain as ATII cells or transdifferentiate into an ATI cells depending on
which cell type they are replacing15.
The second primary function of ATII cells is to synthesize surfactant, store it in
vesicles called lamellar bodies, as secrete it as needed into the alveolus. Surfactant
serves the important job of decreasing the surface tension on the inside of the alveoli. 19
The insides of the alveoli are coated with water, the molecules of which form hydrogen
bonds with one another. Below the surface water molecules are surrounded on all
sides by other molecules so the forces are in equilibrium. However, at the air liquid
interface the forces are unbalanced which causes surface molecules to attach more
strongly to each other than to the air. This gives rise to a surface tension the result of
which is that the water molecules on the interior of the alveoli are highly attracted to
each other. This has the effect of creating a contractile force which both attempts to
collapse the alveoli and makes it more difficult to open them(figure 5). The surfactant
produced by the ATII cells counteracts this surface tension y laying on the surface of the
water and interrupting the hydrogen bonds7,15,20.
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any surfactant present would be such that unassisted inflation of the lungs would not be
possible. The Second important function of the surfactant is to stabilize the air flow
between neighboring alveoli. According to the law of Laplace the collapse pressure on
a sphere is inversely proportional to its radius (figure 5A). This means that the pressure
needed to collapse a smaller alveolus is much less than the pressure required to
collapse a larger one. And since the alveoli collaterally linked through several openings,
this means that normally if one alveolus were less inflated than a neighbor to which it
was attached, all of the air would naturally flow out of the smaller alveolus into the larger
one and the smaller alveolus would totally collapse1,17
The reason why this does not in general happen is because the surfactant
decreases the surface tension more on the less inflated alveoli than on the more inflated
ones. This is simply a result of the fact that the smaller alveolus has the same amount
of surfactant as the larger alveolus but a smaller interior surface over which the
surfactant is spread (figure 5B). And with a more surfactant units per area on the
surface, the surface tension of the alveolus is more completely disrupted. The net result
is that that the collapsing pressure for the alveoli is essentially independent of their
inflation which means that they are stabilized with regards to one another 2,17.
1.1.4 Alveolar Basal Membrane, ECM, and MACs
Directly beneath the ATI and ATII cells both on the interior and exterior of the alveoli is
the alveolar basement membrane. Inside of the basement membrane is an interstitial
space. Contained in this interstitial space are several very important cell types and
structures. Of primary importance are the abundant capillaries that fill this space.
10

These capillaries have an outer covering that consists of a thin basement membrane.
Directly inside of this basement membrane is a single cell thick endothelial layer of
squamous cells which create the capillary wall. Inside of these capillaries are a

constant flow of erythrocytes and plasma18
Figure 6: Alveolar epithelial barrier histology. Reprinted from Kerr et al .
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As the alveoli are ventilated oxygen passes from the open space of the alveolar
sac into the alveolar septa then through the ATI cells then through the alveolar
basement membrane. Once inside the septal wall the oxygen passes through the
interstitia, then through the capillary basement membrane, then through the outer
membrane of the endothelial cells, then through the cytoplasm, then through the inner
membrane into the plasma of the capillary and finally into the erythrocytes themselves.
And carbon dioxide traverses the same path in the opposite direction 5,21. Because the
11

gas exchange that takes place during respiration is passive it is extremely important that
the distance that the gasses traverse be as short as possible (figure 6).
There are several physiological adaptations of the capillary endothelia that help
to facilitate this. The endothelial cells have fewer organelles than other similar
endothelial cells which allow the capillary wall to be stretched particularly thin across
certain areas. Those organelles that they do have are gathered closely to the nucleus
which is itself usually organized axially with the septal wall and or towards the junctions
between ATI cells. This means that while the cells are thick in the regions around the
nucleus they are able to remain very thin for most of their surface that is oriented
towards the ATI cells of the alveolar septa. This thin region of the endothelium that lies
parallel with the alveolar septa is additionally thinned by the fusing of the outer
endothelial membrane with the capillary basement membrane. The result is that on the
face of the endothelium oriented towards the alveolar septa the entire capillary
endothelium is composed of two thin membranes with a tiny amount of intercalated
cytoplasm that’s width totals only 20nm. At some places the entire barrier between the
alveolar air and the blood stream is only 200nm (figure 7).
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Figure 7: (left) Alveolar capillary lined by endothelial cell. (right) Two cell air blood alveolar barrier.
18
Reprinted from Wiebel et al .

13

Figure 8: Collagen and Elastin fiber networks surrounding alveolar epithelium. Reprinted from Toshima
20
et al .

Additionally in this interstitial space there are fibroblasts that manufacture
collagen and elastin fibers. These fibers form bundles that create a collagen and elastin
network that extend from the large airways down to the alveoli and make up the basis
for the physical structure of the septal walls and the lung parenchyma itself (figure 8).
These fibers form dense rings around the alveolar entrances and in the case of elastin
they are interconnected with the elastin networks of the blood vessels. These fiber
networks are responsible for a major component of the lungs mechanical behavior
which we will discuss shortly5–7,21.
Finally, patrolling the interior space of the alveolar septa are alveolar
macrophages that migrate around and phagocytose cellular debris, foreign cells, and
other harmful pathogens (figure 9). Collectively the lung parenchyma are comprised of
the bronchioles, bronchi, blood vessels, alveolar ducts, alveolar sacs, individual alveoli,
and interstitial cells and structures7,22
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Figure 9: Alveolar Macrophage Attacking E Coli Bacteria. Image copyright Dennis Kunkel Microscopy,
Inc23.

1.2 Pulmonary Mechanics
Normal respiration requires that the respiratory zone be continually ventilated, a process
consisting of cycles of the inspiration and subsequent expiration of air. The body
achieves ventilation of the respiratory zone by physically changing the dimensions
thoracic cavity in which the lungs reside. The cavity itself is bounded by on the top and
sides by the thoracic wall by the and by the diaphragm on the bottom. The thoracic wall
is comprised of a layer of interior and exterior intercostal muscles imbedded into which
are the ribs. The diaphragm is a thin musculotendinous dome shaped structure that
separates the thoracic and abdominal cavities7,24
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Immediately surrounding the lungs is a serous membrane called the visceral
pleura. Opposed to it and lining the interior of thoracic wall and diaphragm is another
serous membrane called the parietal pleura. There is a thin fluid filled region in
between them called the interpleural space. Systemic circulation provides the parietal
pleura with high-pressure blood which causes it to constantly secrete fluid into this
space while the visceral pleura is constantly reabsorbing fluid from the space. The
interpleural space is of extreme importance to the normal function of the lungs because
in addition to providing lubrication for the movement of the lungs in the thoracic cavity,
the fluid provides an airtight seal that causes the two membranes to adhere to one
another. This means that any Increasing volume of the thoracic cavity itself also
increases the volume of the lungs and therefore increases the volume of the respiratory
tract. This decreases the internal air pressure of the respiratory tract which in turn
creates an inspiration of air. A subsequent decrease in the volume of the thoracic cavity
increases the pressure in respiratory tract and expires the air 1.
Additionally the interpleural space is important because of the recoil pressure it
applies to the lungs. As we will discuss in more detail later, the elastic nature of the
lungs causes them to have a constant recoil pressure. Normally this would cause them
to collapse, however since the interpleural space is air tight the recoil pressure of the
lungs sets up a negative pressure in the interplural space which balances the recoil
pressure of the lungs and keeps them from collapsing. Because of this, any puncture to
the interplural space that allows air to enter results in the collapse of one or both lungs.
7,24
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The expansion of the thoracic cavity is achieved by the contraction of the
respiratory muscles. During normal or ‘quiet’ breathing the principle muscle responsible
for the expansion of the thoracic wall is the diaphragm with some help from the exterior
intercostal muscles. During quiet breathing the diaphragm contracts and distends 1-2
cm downwards and the thoracic cavity is expanded while the contents of the abdominal
cavity are compressed. In more forceful breathing the expansion of the thoracic wall
benefits from an increased contribution from a large group of accessory muscles
distributed across in the thoracic, back, neck and abdomen. Additionally during maxima
breathing the diaphragm can distend up to 10 cm 7,24.
During cycles of normal ventilation the expiration ends while the airways still
have a positive volume in order to prevent the collapse of the alveolar sacs. We will
discuss the importance of not collapsing the alveoli momentarily. During a normal
maximal inspiration the lungs volume increases approximately fourfold compared to its
end expiratory minimum. This means that the dimensions of the lung are expanding by
roughly a factor of 4

/

= 1.6. Most of this expansion occurs in the alveoli and alveolar

ducts and is isotropic due to surface properties of the liquid on the alveoli and their
collateral airflow24.
During inspiration the parenchymal fibers go from being crimped to being
straightened out (figure 10). Additionally the septal walls begin the inspiration
containing undulations or “crumples” which get smoothed out as the alveoli begin to
inflate. Because these fibers contain elastin, when they are stretched much of the
energy used to stretch them is converted to mechanical potential energy instead of
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being converted to heat. This stored energy means that when lung tissue is expanded it
develops contractile force. This contractile force and the one created by the alveolar
surface tension combine to create the lung's elastic recoil21,24.

Figure 10: (left) Crumpled lung collagen ECM. (right) Inflated lung collagen ECM. Reprinted from
20
Toshima et al .

The elastic properties of lung tissue are generally referred to as compliance and
are written as

/

where

and

are change in lung volume and lung

pressure respectively. This equation means that compliance is defined as the
reciprocal of elasticity. Therefore to better understand the mechanical properties of the
lungs it is important to determine the compliance of both healthy and diseased lungs at
all of the pressures and volumes experienced during ventilation. This is generally done
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by ventilating a lung and measuring the pressure at the airway opening. However, in
order to use our equitation, we must modify it to account for two additional important
mechanical factors. Firstly, our equation must reflect the work that the lung does on the
air as it circulates. Secondly, the thoracic wall to which the lung is attached has elastic
properties of its own which means that the recoil pressure it generates must be included
in our equation as well. When considering these effects if we assume that the lungs
have one degree of freedom (isotropic expansion) then the equations of motion
become25:
=V/C + V˙R + V¨I Where

is the pressure at the airway opening,

is the pressure generated thoracic

walls elastic recoil, V is lung volume, V˙ is gas flow, R is airway resistance, V¨ is
convective gas acceleration, I is impedance, and C is the previously mentioned
compliance.
From this equation we can clearly see the advantages of examining the
compliance of the lung using a model in which the lung is not in motion while
measurements are being taken (static pressure-volume analysis). Additionally because
of the effect of the pressure exerted by the chest wall there is also merit to examination
of a lung that has been excised from the thoracic cavity. Furthermore as previously
discussed both the collagen and elastin fibers and the surface tension of the alveoli
contribute to the lungs elastic recoil. Since the surface tension of the alveoli are
dependent on their having an air liquid interface the effect of the alveolar surface
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tension could be effectively removed by using an experimental model in which the lungs
as ventilated with liquid instead of air. This allows the recoil forces of the lung
parenchyma to be studied independently. Figure 11 contains the pressure volume
loops of an excised cat lung ventilated with both air and saline.

Figure 11: Pressure volume loops obtained from cat lung submerged in saline. Reprinted from Harris et
25
al

Figure 11 contains two very important features. The first is that the recoil
pressures are greater at every volume in the air filled lung than in the saline filled lung.
This means that the surface tension of the alveoli have a substantial effect on the
amount of force needed to inflate the lungs. One obvious implication of this effect is
that liquid ventilation can achieve inspiration and expiration of the lung with the
application of lower pulmonary pressure than conventional gas ventilation 24,25.
The second important feature of the graph is that there is a much greater
separation between the inflation and deflation limbs of the air filled lung than the saline
filled lung. At any given volume the air filled lung has a much greater recoil pressure
20

during its inflation that its deflation. Because the graph is of pressure versus
displacement the difference in the two graphs represents the hysteresis of the lungs
during ventilation. Therefore this graph demonstrates that the majority of the hysteresis
of the lungs during ventilation is due to the surface tension of the alveoli 7,24,25.
While giving us information about the role of alveolar surface tension, this model
fails to investigate the relationship of the elastic recoil of the thoracic wall and that of the
lungs. In order to do investigate this we must first create an equation that relates the
compliance of the lungs and that of the thoracic wall independently and in combination.
If we treat the thoracic wall and the lungs like two elements in series the equation for the
compliance of the combined system is equal to the sum of the reciprocal of the two
elements individually or:
1/
Where

= 1/

is the compliance of the thoracic wall,

+ 1/
is the compliance of the lungs, and

is the compliance of the combined respiratory system.

and

can then be

calculated independently. At pressures controlled through mechanical ventilation the
changes in the volume of the wall can be directly observed as the distention of the
diaphragm is inferred from of the movement of the abdomen.
When the

, the

, and the resultant

values are measured, calculated,

and graphed respectively for an adult human we get the graph in figure 12 as a result.
TLC is total lung capacity, FRC is function reserve volume (the volume of air remaining
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in the lungs after normal exhalation) and RV is residual volume(the volume of air in the
lungs after maximal exhalation)7,24,25.
The graph in figure 12 has several important features. Firstly when we look at
the graph of the lung compliance we see that at its minimum volume its pressure and
volume never go to zero. Additionally as its volume increases its compliance has a
relatively linear region then drops off sharply. This is the type of behavior we would
expect to see in biological tissue whose elastic properties come from elastin and
collagen fibers since we know that they have a tendency to behave in a linearly elastic
fashion until they are fully stretched out then have a sharp drop off in compliance.
Secondly when we observe the thoracic wall graph we see that it has no elastic recoil
pressure when its volume is equal to around 4L (figure 12). When its volume is less
than 4L it has a negative recoil pressure which means it attempts to expand.
Additionally because the thoracic wall’s compliance decreases with decreasing volume,
the amount of pressure needed to continue to decrease its volume continues to
increase. When we analyze the combined graph we soon see why this is important.
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Figure 12: PV graph of combined chest and lung wall mechanics. Reprinted from Harris et al
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The net effect of the combination of the two graphs is that at low volumes the
negative elastic recoil pressure of the thoracic cavity dominates the compliance of the
system. This is beneficial because for all volumes lower than the FRC the recoil
pressure on the lungs attempts to inflate them. This means that inflating the lungs from
any volume below the FRC to the FRC takes no energy which helps to maintain the
residual lung volume needed to prevent the alveoli from collapsing. And at larger
volumes the elastic recoil of the lungs dominates the system which is beneficial
because it both allows the mechanical energy of inspiration to be stored physically in
the arrangement of the fibers so that expiration requires less energy, and it prevents the
over inflation of the lungs and alveoli7,24,25.
In order to determine if there are any other mechanical benefits to the function of
the lungs during respiration contributed by the elastic properties of the lungs we can
observe the pressure-volume graphs for experiments in which the lungs are made to
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inflate at pressures below the FRC. In this experiment cats were ventilated using a
negative pressure ventilators beginning at pressures both above and below their FRC
(figure 13). The most important features of this graph are that while the pressurevolume curve for the expirations seems to be independent of the starting volume, the
curve of the inspiration is shifted downwards when the lungs are inflated from below the
FRC. This means that it requires more energy and more energy is lost when the lungs
inspiration begins below the FRC.

Figure 13: Graph of lung inflation below FRC. Reprinted from Harris et al .
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We can also note that this graph (figure 13) has a much lower hysteresis than the one
we observed previously in the air ventilated cat lung. This seeming disagreement can
be resolved by replicating this experiment with an excised lung 7,24,25.
Here we see a similar set of pressure-volume curves when the initial volume for
this extracted of lung is close FRC for the intact lung. However, we see that if we allow
the lungs initial volume to go to zero and the lungs and alveoli to completely collapse we
get a graph that matches our first experimental graph of the excised cat lung. From this
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was can clearly see that the amount of energy list to hysteresis when the lungs are
allowed to fully collapse is significantly larger than the amount of energy lost to during
normal ventilation25.
1.3.0 Ventilator Induced Lung Injury and Pulmonary Edema
Many pathophysiological states can result in a person’s inability to adequately ventilate
their lungs with spontaneous breathing which makes mechanical ventilation a necessary
and potentially lifesaving clinical intervention. These pathological states include Acute
Lung Injury (ALI), Acute Respiratory Distress Syndrome (ARDS), Pneumonia, Asthma,
and Chronic Obstructive Pulmonary Disease (COPD)26–28. It is estimated that annually
there are 800 thousand hospitalizations in the United States requiring mechanical
ventilation with an estimated in-hospital mortality rate of 34.5%. This represents 2.7
episodes of mechanical ventilation and .9 deaths per 1000 individuals in the U.S. This
means that pathological conditions requiring mechanical ventilation lead to more deaths
annually than breast cancer and prostate cancer combined. The national costs of
mechanical ventilation are estimated at $27 billion dollars per year and account for 12%
of all hospital costs in the United States29.
1.3.1 Impact of VILI
Despite its necessity as a potentially life-saving clinical intervention, mechanical
ventilation (MV) can result in ventilator induced lung injury (VILI). The three proposed
mechanisms of VILI are over-distention of the alveoli (volutrauma), cyclic recruitment
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and derecruitment of the alveoli (atelectatrauma), and secondary injury caused by the
stretch or injury-induced release of inflammatory cytokines (biotrauma)

Figure 14: Flow chart of the mechanisms of VILI. Reprinted from Carrasco et al

27,30

(figure 14).
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The largest population of patients requiring MV is the elderly29, and age is a
known predictor for the severity of VILI32. As people age the chest wall becomes less
compliant, the lung parenchyma loses elasticity, the average alveolar diameter
increases, and overall lung capacity diminishes

10,33

. Additionally over time the lungs

capacity to recover from injury diminishes and its inflammatory responses increase 34.
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These physiological changes in the aging lung correlate to each of the proposed
mechanisms of VILI. Accordingly age is a predictive factor in the severity of VILI;
however, the exact relationship between age and the severity of VILI is currently
unknown. The increase in the severity of VILI with patient age combined with the
increased need for ventilation and mortality rate among the elderly makes the
investigation of this relationship even more important.
A consistent feature in all of the proposed mechanisms of injury is that they occur
at the level of the alveoli27 (figure 15). This would seem to suggest that there is a
meaningful substantive difference between the physiological and mechanical behaviors
of healthy lung alveoli under spontaneous breathing and in alveoli being injuriously
mechanically ventilated. It would also seem to suggest that there are age related
changes in these physiological and mechanical behaviors that play an important role in
the severity of VILI.

Figure 15: Diagram of the alveolar mechanisms of VILI. Reprinted from Reynaud et al
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1.3.2 Biotrauma
Both through mechanotransduction and cell/tissue injury, MV has been shown to upregulate the production and excretion of inflammatory cytokines in the lung, which in
turn can further aggravate lung injury. Stress failure of the alveolar barrier
(decompartimentalisation) and stress failure of the plasma membrane (necrosis) have
been shown to release cytokines into the lung as well as into systemic circulation 35.
Mechanotransduction is also sufficient to cause the release of cytokines into the lung.
In one study, Bronco alveolar lavage fluid (BALF) concentrations of TNF-a and
interleukin (IL) 6 were elevated in infants without prior lung injury who were treated with
MV for whom no clinically obvious harmful effects of MV were observed 36.
In addition to the release of cytokines, biotrauma is an upstream regulator for the
recruitment and extravasation of leucocytes in the lung37,38. The biotrauma associated
with adult acute lung injury and neonatal chronic lung disease has also been shown to
delay leucocyte apoptosis 39,40and cause apoptosis of pulmonary epithelial cells.
Not surprisingly the immune and inflammatory response by to injurious
mechanics stretch is not localized to the lungs 41. The majority of patients who die from
acute respiratory distress (ARDS) die from multiple organ dysfunction syndrome
(MODS)41. Concentration differences across the lung (difference between arterial and
mixed venous) of inflammatory mediators have been detected in patients with ALI with
ARDS42,43, indicating a significant release of these pro-inflammatory molecules by lung
tissue. In one study, rabbits treated with injurious MV showed significantly increased
renal apoptosis, renal dysfunction, and small intestine apoptosis compared to rabbits
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receiving a protective ventilation strategy44. An ARDS network study has also shown
that after three days with of either high or low tidal volume MVs, patients with low tidal
volumes have lower serum level of IL-6, increased organ failure-free days, and lower
mortality than those with high tidal volume ventilation 45,46. Understanding the
mechanisms of VILI-associated biotrauma could prove critical for increasing survival in
ventilated patients.
A direct investigation of the of the effect that age has on the lungs immune and
inflammatory response to mechanical stretch and ventilation can be accomplished in a
relatively straightforward manner using scientific methods currently in use. The alveolar
epithelial cells of young and elderly mice can be harvested, grown in culture, and
exposed to cyclic mechanical stretch40,47. Those cells can then be assayed for cell
damage/survival/proliferation, their media can be assayed for the presence of
inflammatory cytokines and total protein, and their proinflammatory gene expression
can be measured using QPCR. Likewise young and elderly mice can be mechanically
ventilated; the mechanical properties of their airways as a whole can be measured, their
airways can be lavaged with saline to collect and measure inflammatory mediators and
their lungs can be fixed and analyzed with histology/microscopy. These are all methods
of analysis that we employed our study to measure and quantify the effect of how aging
affect the lung and how this intern affects the severity of VILI.
1.3.3 Pulmonary Edema
In the human body, the existence of interstitial colloidal osmotic pressure and capillary
filtration pressure causes the filtration of about 20 liters of water out of the blood stream
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into the surrounding tissues per day. This creates a need for an opposing gradient in
order to prevent the accumulation of filtered water in these tissues (edema). In the
absence of pathological conditions, these gradients roughly balance one another with
approximately 17 liters of water being filtrated directly back into the circulatory system
and the remaining 3 liters being taken up by the lymphatic system and then returned to
circulation48.
This balance is of particular importance in the distal lung because pulmonary gas
exchange occurs at the air liquid interface of the alveoli and thus maintenance of this
interface critical for normal lung function. Not surprisingly the accumulation of water in
the lung alveoli (pulmonary alveolar edema) can lead to dramatic dysfunction of
pulmonary gas exchange and is potentially fatal 9,48.
Both increases in vascular pressure, increases in alveolar vascular permeability,
and increases in alveolar epithelial barrier permeability have been demonstrated to
drive pulmonary edema. Additionally each of these forms of dysfunction are known to
exist in various pathological lung conditions including acute respiratory distress
syndrome (ARDS) and ventilator induced lung injury (VILI)49.
1.3.4 Alveolar Fluid Clearance
In the healthy lung, the mechanism for the clearance of alveolar edema is primarily
linked to that the transportation of sodium and chloride ions out of the alveolus into the
alveolar capillaries and surrounding interstitial space. This creates an osmotic pressure
gradient which drives alveolar fluid clearance into the bloodstream, pleural space, and
lymphatic system. Both alveolar epithelial ATI and ATII cells (ATIs, ATIIs) contain
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sodium/potassium ATPase pumps (Na/K-ATPase). In addition ATI cells contain the
epithelial sodium channel (ENaC), the nonselective cation channels (NCC), the cyclic
nucleotide–gated channels (CNG), and other selective cation channels (SCC). Chloride
ions are able to pass through alveolar epithelium through either a trans or paracellular
route48,50.
The gradient that is caused by sodium transport causes water to be transported
by both aquaporin (AQP) 1, and 5, and through paracellular pathways. However, the
exact breakdown of how this happens is not immediately clear. There is experimental
evidence that in young rats that have AQP-1 and 2 knockout out, both separately and
together, that there is no significant inhibition of alveolar edema clearance. However, it
has also been demonstrated that the experimentally induced up regulation of the
expression of AQPs that were down regulated by age restores age related losses in
pulmonary edema clearance function in aged mice50–52.
1.3.5 VILI-Associated Edema
Edema is a hallmark complication of VILI and acts through several distinct
pathways. VILI has been shown to increase lung microvascular pressure and
transmural pressure and to drive water filtration into the alveolus. Mechanical
ventilation (MV) has also been shown to inactivate surfactant within the alveolus. This
increases alveolar surface tension which in turn has been shown to increase filtration
from the microvasculature into the alveolus52,53.
All of these effects however contribute insufficiently to pulmonary edema to
account for the pathophysiological state caused by MV. Instead it is a VILI induced
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increased in the alveolar epithelial barrier permeability that accounts for the majority the
observed edema. It is known that VILI-associated volutrauma can strongly promote
pulmonary edema. In one study, during static inflation of sheep lungs the equivalent
pore radius of the alveolar epithelial barrier (an indicator of barrier permeability)
increase from 1 to 5 nm. This fivefold increase was sufficient to allow albumin to diffuse
freely across the barrier, indicating a major compromise to barrier integrity. This
increased permeability persisted or even increased after the cessation of inflation,
confirming that epithelial barrier damage and not vascular pressure were driving this
increase in permeability52.
Additionally, multiple animal models have also shown that when MV with high
peak pressures causes pulmonary edema, histological analysis inevitably reveals stress
failure of the alveolar barrier (decompartimentalisation), stress failure of the plasma
membrane (necrosis), visible denuding of the epithelial basement membrane, and gaps
in the capillary epithelium50,52,53.
In addition to primary lung injury sustained through volutrauma, secondary injury
to the lungs and systemic organs systems through the release of inflammatory
cytokines (biotrauma) is another major mechanism in the pathogenic process of
VILI. Inflammatory cytokines are known to have a profound effect on epithelial barrier
integrity. TNF-alpha and IL-1, 6, and 8 are all known to increase the leakiness of tight
junctions, and are all associated with VILI Induced biotrauma 54. In this way, VILI is able
to contribute to edema through both direct insult to the alveolar barrier integrity, and
through the release of inflammatory cytokines which further compromise membrane
permeability41,53.
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1.3.6 Age, Edema, and VILI
Increased age is known to increase the severity of both VILI and edema
separately. The changing mechanical properties of the aging lung lead to increases in
lung compliance which increases the lung susceptibility to over-distention during
MV27,29,41,55,56. Additionally, the aging lung also exhibits an increasingly dysregulated
immune/inflammatory response to injury which has a generally pro-inflammatory
effect57,58 It has been shown in rats that increased age leads to increased lung
damage/inflammation and animal mortality in rats that are ventilated with high tidal
volumes compared to young rats59. This is in good agreement with the murine data we
present in chapter two. It has also been shown that age is a predictive factor in the
incidence and severity of pulmonary edema. Aging is known to decrease the
expression of AQP 1 and 5 in the alveolar membrane of rats which leads to an increase
in pulmonary edema60. Additionally, our own data presented in chapter two
demonstrate that elderly mice treated with injurious MV show both increases in
pulmonary edema and decreases in 4 hour survival compared to similarly ventilated
younger mice.
1.3.7 Fluid Support and Hemodynamics During MV
MV has a strong effect on a patient's hemodynamics. Overall, MV has a tendency to
decrease blood pressure and cardiac output. In addition to strong insult to the
cardiovascular system, prolonged dysfunction of the circulation is also extremely
stressful on a patient’s renal system. These MV related complications can prove to be
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fatal to patients with already in compromised pathophysiological states 49,61. For this
reason there is a general concern among clinicians regarding an attempt to normalize
the hemodynamics of ventilator patients. Although the exact effects are still being
debated, fluid support has been shown to increase the blood pressure and improve the
overall hemodynamics in ventilated rats61. However, the same study showed that these
rats, while having improved hemodynamics, displayed increases in edema and
anemia. Additionally, in human ventilation patients it has been shown that conservative
fluid management strategies decrease pulmonary edema.
These results may at first be somewhat surprising since it has been established
ventilation induced pulmonary edema is caused primarily by decreases alveolar
membrane permeability and not modified hemodynamics in the alveolus. Thus the
impact of this and other studies that correlate high volume fluid-management with
pulmonary edema is that once alveolar barrier permeability is compromised, only minor
increases in intravascular pressure and drops in ontotic pressure are required to
generate large edema. The molecular aspects that influence pulmonary edema, both
upstream and downstream, are currently understudied. One key player in the
mechanism may be stress in the endoplasmic reticulum.

1.4.0 ER Stress Background
Protein molecules are vital players in virtually every cellular process. However, their
useful bioactivity is not an innate property imbued through their synthesis by the
ribosomes alone. Instead each nascent polypeptide chain must go through a
conformational change into its characteristic or ‘native’ 3 dimensional form in order to
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have its full physiological functionality62,63. Every part of the protein formation process
that occurs after translation of the polypeptide chain by is known as protein folding. For
proteins that are eventually to be secreted out of the cell or sorted to other organelles
this folding takes place takes place in the cisternae of the Endoplasmic Reticulum
(ER)37.
The ER itself is a membrane enclosed organelle performing numerous cellular
functions including lipid biosynthesis and calcium storage and sequestration. However,
arguably the most important function of the ER is its role as the site of protein folding as
the majority of its resident proteins are dedicated to this process64. An N-terminal signal
sequence on these proteins interacts with a signal recognition particle (SRP) which lead
the RNA, Ribosome, polypeptide complex to the ER. Once docked, the sequence is
translated directly into the luminal environment of the ER. The folding process itself
may start as soon as the nascent polypeptide chain begins to enter the ER while the
rest of the chain is still undergoing translation. Thus the N-terminus of the polypeptide
chain may undergo folding while the while the C-terminal is still being synthesized 64,65.
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The native states of almost all proteins correspond to the three dimensional
conformation of their nascent polypeptide coil that are the most thermodynamically
stable under physiological conditions

66

. Therefore although one might imagine a linear

set of consecutive folding steps that leads each protein from nascent to native, the
protein instead meanders down an energy landscape (figure 16).

Figure 16: A schematic energy landscape for protein folding. Reprinted from Reynaud et al .
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And although the potential paths are many, at each step the protein chooses a
new conformation that further reduces its free energy until, if all goes well, it arrives at
its native conformation. This means that ultimately is it the amino acid sequence itself
that determines native conformation of each resultant protein 66.
36

However, because it is a stepwise process, it is a certainly the case that at
intermediate stages of this process some regions that would normally be hidden inside
the protein during its native conformation are exposed to the crowded milieu of the
ER68. This leaves intermediately folded proteins vulnerable and prone to inappropriate
interactions with other molecules. In the case of exposed hydrophobic residues
intermediate or misfolded proteins will have a strong tendency to aggregate together. In
all as many as 30% of synthesized proteins never attain their fully native conformation 69.
All hope is not lost however. The cell has evolved a quality control system to
bolster the success of this folding process. The folding process inside the ER is
assisted at every stage by molecular chaperones and ER folding enzymes 65. Molecular
chaperones are proteins that aid other proteins to attain their native conformation but
are not part of the final protein structure. In the ER protein folding process the primary
function of the molecular chaperones is to shield the hydrophobic binding sites of the
intermediate or misfolded proteins. Different chaperones specialize in assisting at
various different stages of the folding process. Some chaperones assist the nascent
protein as they are being translocated into the ER while others aide the final
conformation into native proteins. But in all cases along this continuum these
chaperones effectively sequester the proteins and provide them with a privileged folding
environment to prevent premature folding or aggregation. There are still other
chaperones that have the ability to ‘rescue’ misfolded or aggregated proteins and allow
them to attempt to refold properly 66,70(figure 17).
But for proteins who are hopelessly misfolded or aggregated there are multiple
chaperones and folding sensors that have the ability to identify them. These proteins
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are then transported outside of the cell and degraded. Because there are very few
protein folding chaperones anywhere else in the body it is crucial that highly efficient
quality control system be in place to prevent misfolded proteins from being packaged
transported out of the ER71.

Figure 17: Regulation of protein folding in the ER. Reprinted from Reynaud et al 67

As the folding of the ER proteins is guided by the chemical forces acting on the
polypeptide sequences, the maintenance of homeostasis of the ER environment is
critical for this process. There are many pathophysiological conditions however that can
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perturb this delicate balance including disruptions in calcium homeostasis,
glucose/energy deprivation, redox changes, ischemia, hyperhomocystinemia, and viral
infections and mutations. This impairment in folding can cause an increasing
accumulation of unfolded and/or aggregated proteins known as ER Stress 72.
The evolved response to ER Stress is known as the unfolded protein response
(UPR) and consists primarily of three branches. The signaling of each branch is
transduced across the ER membrane through a one of three transmembrane proteins:
PKR like ER kinase (PERK), inositol requiring element-1 (IRE-1), and activating
transcription factor 6 (ATF6). Each of these three proteins are held inactive by being
bound to BiP, a peptide-dependent ATPase and member of the heat shock 70 protein
family. However, when the unfolded/aggregated proteins begin to accumulate BiP
dissociates from the three signaling molecules and they become active (figure 18) 73.
IRE1 dimerizes then auto-transphosphoyilizes. It then produces the mRNA
which encodes unspliced x box-binding protein 1 (XBP1u) to produce active
transcription factor spliced (XBP1s)74. XBP1s which includes the transcription factors
for several molecular chaperones including BiP and GRP94. XBP1s also encodes for
the transcription of genes associated with ER-associated degradation (ERAD). The net
effect is an increase in the available protein folding chaperones and an upregulation of
the degradation of misfolded proteins.
PERK phosphorylates initiation factor eukaryotic translation initiator factor 2α
(eIF2α) which inhibits general translation into the cell with the exception of BiP and
ATF4 which are instead translated more efficiently75. PERK also inhibits several
transcription factors. This general decrease in the rate at which proteins are being
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transcribed into the ER gives the protein folding apparatus extra time to try to clear the
accumulation of misfolded proteins. PERK also upregulates Nrf2 which upregulates
antioxidant response76. This is of particular importance in understanding the therapeutic
potential of VitC to attenuate ER stress. VitC is a powerful anti-inflammatory and antioxidant77 both of which have the potential to strongly interact with the ER stress
pathway.

Figure 18: Diagram of ER Stress Pathway. Reprinted from Reynaud et al72

ATF6 is localized in the ER membrane when the ER is unstressed. When
cleaved from BiP AFT6 is transported to the golgi apparatus where it is cleaved. The
cytosolic dominant fragment (ATF6f) upregulates expression of the gene encoding for
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ERAD and XBP178. As discussed above the upregulation of these genes stimulates
degradation of misfolded proteins.
If the ER stress continues unabated however it leads to pro-apoptotic signaling
and cell death. The ER stress induced is mediated primarily through C/EBP
homologous protein (CHOP) also known as growth arrest and DNA damage 153
(GADD 153) which downregulates the anti-apoptotic protein BCL-2, induces the
expression of some BH3-only proteins and upregulates growth arrest and DNA
damage-inducible 34 (GADD34)65. CHOP is downstream of both the PERK and ATF6
pathways. The PERK induced eIF2 in the presence of sustained ER stress will
upregulate nuclear factor-kappaB (NFκB) and ATF4. And under prolonged ER stress
ATF4 in turn upregulates CHOP. IRE1a may upregulate p53 which along with ATF4
and CHOP may upregulate BH3-only proteins79.

Figure 19: Time dependent ER stress pathway. Reprinted from Hetz et al .
79
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As we can see from the above diagram there is a balance between adaptive
responses to ER stress and the apoptosis phase whose nature is such that failure to
sufficiently resolve the UPR will upregulate apoptosis (figure 19) 79. Predictably there
are many disease states in which ER stress plays a key role.
We know that as people age there is a general shift away from the adaptive
phase of the UPR towards the apoptotic signaling pathway72. In addition to promoting
inflammation, this age-associated decrease in the efficiency of the UPR also leads to
the accumulation of insoluble proteins or plagues in a variety of organs including the
liver, spleen, or brain. This in turn contributes to a host of age-associated pathologies
including age-related neurodegenerative disorders. For example protein aggregation is
a hallmark of Alzheimer's disease, Parkinson’s, and prion disease 80. It was
experimentally determined that under basal conditions that the expression of
chaperones calnexin, protein disulfide isomerase (PDI), and Grp78 are downregulated
in the aged hypothalamus81. Each of these chaperones is a constituent in the normal
protein folding process. Conversely, ubiquitination which plays a key role in the
apoptotic arm of the UPR pathway is increased in the aged hippocampus. The
downstream effects of this pattern were experimentally confirmed as well. When ER
stress was induced in young VS old rats via intra-hippocampal lactacystin injection the
old rats expressed less folding chaperones and Caspase-12 and young did not 81.
Key protein folding chaperones BiP, PDI, calnexin and GRP94 also become
increasingly impaired with age82,83. Over time these chaperones become increasingly
oxidized which may impair their functionality. For several of these chaperones
reductions in oxidation correlate significantly with diminished enzymatic activity.
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The universality of both aging and ER stress makes any interaction between them as
ubiquitous as even the most common of pathologies. It is thus not surprising that as we
continue to further investigate this interaction that we are compiling an ever growing list
of diseases of aging in which ER stress is a key factor. Our ultimate goal is to discern
the role of aging and ER stress in VILI.
1.5 Specific Aims
Despite its necessity as a potentially life-saving clinical intervention, MV can result in
ventilator induced lung injury (VILI). The proposed mechanisms of VILI (volutrauma/,
atelectrauma, biotrauma) were discussed in chapter one of this dissertation. Also as we
discussed previously age is a predictive factor in the severity of VILI and the largest
population of patients requiring MV is the elderly. However, the exact relationship
thought which age-associated changes in pulmonary physiology interact with VILI is not
well understood which has made it difficult for physicians to create age-dependent
ventilator protocols or preventative treatments for VILI.
We hypothesized that there is an overall age-associated increase in the severity
of the ventilator induced lung injuries that act to promote pulmonary edema. We
hypothesized that this upregulation of edema promoting stimulus synergizes with a
general and independent age-associated increase in the susceptibility to and severity of
pulmonary edema. Furthermore we hypothesized that this age-associated increase in
the severity of VILI induced pulmonary edema itself promotes further injury and
inflammation which in turn positively feeds back to further promote edema and injury.

43

We believed this VILI induced positive feedback loop through the pulmonary
edema pathway is ultimately an important cause of the age-associated increase in
ventilator-associated mortality. And finally we hypothesize that since the primary
mechanical driving force which filters fluid into the lungs is trans pulmonary pressure, if
we administered a low fluid protocol to our murine subjects it would attenuate their ageassociated increase in VILI-assocaited edema, inflammation, injury and mortality.
We tested this hypothesis in vivo by mechanically ventilating young (8 weeks)
and old (20 months) mice with either a high tidal volume (HVT) or low tidal volume
(LVT) ventilation protocols and with either a conservative or liberal fluid treatment
protocol. During ventilation we measured subjects’ pulmonary mechanics and mortality
rates. Concluding ventilation we measured pulmonary edema, histological lung injury,
and relative cytokine population in the alveolar lavage fluid.
Specific Aim 1:

Measure the effect of novel low fluid treatment protocol on the ageassociated increase in the severity of VILI and ventilator induced
mortality.

We also hypothesized that the known age-associated increase in the susceptibility and
severity of ER stress is a causal mechanism in the age-associated increase in the
severity of ventilator-associated biotrauma. We hypothesized that old ATII cells
themselves exhibit greater inflammation and injury downstream of an age-associated
increase in mechanical stretch induced ER stress. Additionally, since we hypothesized
ER stress as being upstream of this age-associated increase in stretch induced
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inflammation and injury, we further hypothesized that treatment with an ER stress
inhibitor would attenuate both the ER Stress and inflammation/injury as well. We tested
this hypothesis in vitro by harvesting and culturing the alveolar epithelial ATII cells of
young and old mice, exposing them to cyclic mechanical stretch, and measuring their
inflammation and injury. Cells were treated with either an ER stress inhibitor or sham
control.
Specific Aim 2:

Determine if ER stress is an upstream regulator of age-associated
mechanical stretch induced inflammation and injury in primary
alveolar epithelial ATII cells.

In mice, VitC deficiency has been shown to increase the severity of acute lung injury
(ALI) and pulmonary edema. Treatment with injections of VitC has been proven to
attenuate these effects both in VitC deficient and sufficient mice[8]. Knowing the
mechanistic role that pulmonary edema plays in the age-associated increase in the
severity VILI, we hypothesized that VitC treatments would resolve edema and confer a
protective effect on old murine ventilation subjects.
Specific Aim 3:

Evaluate the efficacy of VitC as a treatment for Edema and VILI in
old mice.

When taken together, these data greatly enhance our working understanding of the
mechanistic relationships that drive the age-associated increase in the severity of VILI.
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Even more importantly the resolution of each of these aims provides a much needed
therapeutic target for preventative VILI treatments.
2.0
Conservative Fluid Management Prevents Age-Associated Ventilator Induced
Mortality
A research paper on by our group on which I was the primary author titled
“Conservative Fluid Management Prevents Age-Associated Ventilator Induced Mortality”
was successfully submitted and published to the Journal of Experimental Gerontology.
This chapter is contains the body of that work as published.
2.1.0 Introduction
Advanced age is known to beventilator-associated with increased severity of ventilatorinduced lung injury (VILI) 29. Setzer et al recently demonstrated that HVT (24 ml/kg) MV
caused more lung injury in old rat subjects than in their younger counterparts. Lung wet
to dry rations, lavage protein and cytokine concentrations, and systemic markers of
inflammation were all elevated in the older HVT MV subjects 59. Additionally, it has been
shown that short-term mechanical ventilation with low tidal volume and hyperoxia
increases pulmonary edema, lung inflammation, and decreases diaphragm function in
old rats subjects compared to young adults

. However, the exact mechanism(s)
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through which this relationship between aging and VILI is mediated remain ill defined.
Consequently, preventative strategies for the age-associated increase in ventilator
mortality are currently unknown. The changing mechanical properties of the aging lung
46

lead to increases in lung compliance which can predispose the lung to over-distention
and increased susceptibility to atelectasis during mechanical ventilation

41,55,56,85

.

Further, the aging lung exhibits increasingly dysregulated immune/inflammatory
responses to injury leading to pathological increases in pro-inflammatory behavior

57,59

.

Pulmonary edema is a hallmark of VILI 53. The incidence and in-hospital mortality
rates of patients presenting with pulmonary edema is also known to increase with
patient age86,87. Both the presence of pulmonary edema in ventilated patients and their
overall survival rates can be affected by fluid management strategies61. Recent studies
show that conservative fluid management can decrease pulmonary edema, increase
ventilator free days, and increase overall survival of patients with acute respiratory
distress syndrome (ARDS)

59,88

. However, patients undergoing mechanical ventilation

with inadequate fluid support are also at risk of developing hypovolemia which overtime
can lead to multiple organ system failure 28. Therefore administering optimal fluid
balance is crucial for mechanical ventilator patient survival and recovery. Despite
known benefits of conservative fluid protocols for patients with ARDS, its effects on VILI,
interaction with patient age, and the role that they both may play in ventilator-associated
mortality rates has yet to be established.
We hypothesized that high tidal volume (HVT) mechanical ventilation would
induce lung injury, degrade pulmonary mechanics, and increase pulmonary edema in
older murine subjects. Further, we hypothesized that a greater sensitivity to these
pathologies would result in an age-associated increase in ventilator-associated
mortality. Finally, we hypothesized that age-associated increases in injury and mortality
could be attenuated with a conservative fluid support strategy. To establish the role
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pulmonary edema plays in age-associated increases in VILI and ventilator-associated
mortality and to evaluate fluid support protocols as a potential preventative treatment,
we investigated the outcomes of both liberal and conservative fluid support strategies
during high and low tidal volume mechanical ventilation in both young and old mice.
2.2.0 Materials and Methods
2.2.1 Animal Use: This study was approved by the VCU Institutional Animal Care and
Use Committee (protocol number AD10000465). Male C57BL6 mice were used in
these experiments. All animal experiments were carried out under IACUC University
guidelines.
2.2.2 Age Groups: Age group I (Young): Young adult animals, 2-3 months of age,
weighing 25 ± 3 g. Age group II (Old): Old animals, 20-22 months of age, weighing 35 ±
11 g. Ages of our young and old murine groups respectively were based on correlations
between murine lifespan and known age-associated morphological changes in murine
lung (17)(29).
2.2.3 Mechanical Ventilation: Young and old animal subjects were anesthetized with
an intraperitoneal (IP) injection of 80mg/kg pentobarbital. In addition to anesthesia our
MV regimen required that we arrest the subjects’ spontaneous breathing with
administration of a paralytic. This was accomplished with IP injection of 0.8 mg/kg
pancuronium bromide at the 0hr and 2hr time points. Depth of subject anesthesia was
monitored continuously via EKG transducer monitors included in FlexiVent small animal
ventilator (Scireq) hardware. To maintain an appropriate level of anesthesia over the
course of ventilation pentobarbital redoses of 40mg/kg were administered as needed
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when subject heart rate exceeded 350 bpm. Each subject was randomized into the
following treatment groups according to age: Young Low Tidal Volume (LVT), Young
High Tidal Volume (HVT), Old LVT, and Old HVT. Following group assignment,
subjects were mechanically ventilated with either LVT (8mL/kg, 125 BPM, 3cm H 20
positive end expiratory pressure, [PEEP]) or HVT (25mL/kg for Young, 18mL/kg for Old,
90 BPM, 0cm H20 PEEP) ventilation protocol for either 1hr or 4hrs using a FlexiVent
small animal ventilator (Scireq). LVT and HVT ventilation patterns and four-hour
ventilation protocol were based on previously published in vivo models 89. Difference in
tidal volumes of young and old HVT groups reflects a normalization of tidal volume
across age based upon ideal body weight. Mice are considered to be adult at 2-3
months, but our measurements indicated that our 20-22 month old animal subjects were
on average ~30% more massive than their younger counterparts. To better replicate
clinical protocols the tidal volumes for our HVT ventilation were established using
ideal/predicted body weights. The tidal volume for the old HVT group was therefore
multiplied by 0.7, or the ratio of the average weight of the young subjects to that of the
old. This gave an adjusted average tidal volume of 625ul±50ul and 630ul±62ul for the
young and old HVT groups respectively.
2.2.4 Fluid Support Protocol: Animal subjects were administered either liberal (high)
or conservative (low) fluid management protocols. Animals managed under high fluid
received anesthesia with pentobarbital at a concentration of 10 mg/ml in saline and
received IP infusions of saline at 100µL/hr. For a 25 gram subject requiring an hourly
redose of pentobarbital the total 4hr saline infusion volume would be ~1ml. Animals
managed under low fluid protocol were anesthetized with pentobarbital at 20 mg/ml and
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received no IP saline infusions. For a 25 gram subject requiring an hourly redose of
pentobarbital the total 4hr saline infusion volume would be ~0.35ml.
2.2.5 Lung Mechanics: At the 0, 1, 2, 3, and 4hr time points the following forced
inspiratory maneuvers: 1) Deep Inflation v7.0, 2) Snapshot-150 v7.0, and 3) PVs-V v7.0
were performed using the included FlexiWare software package (Scireq). Deep inflation
acts as a recruitment maneuver and measures total lung capacity (TLC). Snapshot
measures lung tissue compliance. The pressure volume (PV) maneuver inflates the
lung to a sequence of linearly increasing then decreasing volumes while measuring the
corresponding airway pressures. With these data the PV maneuver generates
respiratory pressure-volume loops from which the PV-loop area (hysteresis) is
calculated. For subjects who died during ventilation the last set of mechanical data
points taken prior to death were included in analysis where possible.
2.2.6 Euthanasia: At the end of the 1hr and 4hr ventilations respectively each animal
subject was fully exsanguinated and removed from mechanical ventilation.
2.2.7 Bronchoalveolar Lavage Fluid Collection: Bronchoalveolar lavage was
performed by instillation of saline using gravity feed driven flow at a height 30cm. This
method was preferred over a forced installation to preserve lung architecture for
histological analysis of alveolar airspace enlargement. Saline flowed freely into the lung
until it stopped naturally. The installation tube and mouse were then inverted to allow
the saline to flow freely back out and into a collection tube. This process was repeated
three times. An average of 2.5 - 3.5mls of total bronchoalveolar lavage fluid (BALF) per
subject was obtained using this technique.
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2.2.8 Bronchoalveolar Lavage Fluid Cytology: BAL fluid was centrifuged at 300 x G,
4°C for 8 minutes. Supernatants were removed and cell pellets re-suspended in saline.
Cells were then mounted onto glass slides using a cytospin device (Shandon). Cells
were stained (3 Diff-Quik solutions staining kit) and cover-slipped. Cell populations
were then analyzed using microscopy (Olympus) and the ratios of lymphocytes,
leukocytes, and macrophages were determined.
2.2.9 Bronchoalveolar Lavage Fluid Protein Concentration: BCA assay analysis
(Pierce) of protein concentration was performed on all BAL fluid supernatants according
to manufacturer’s instructions.
2.2.10 Lung Histology: Left lungs were held at constant pressure, fixed with 10%
formalin, sectioned, and stained with H&E. Airspace enlargement, which quantifies
relative differences in alveolar airspace area within lung histology sections, was
measured and analyzed using in-house custom code written in MATLAB. This code
quantified enlargement using a previously defined mean weighted enlargement metric
(18). The weight of each airspace in the metric was dependent on the variance and
skewness of its size. Stained slides were dehydrated and mounted using Permount
mounting medium (Fisher) and imaged using an Olympus IX71 Microscope (Olympus).
2.2.11 Lung Wet to Dry Weight Ratios: From each animal subject, right lungs were
excised, weighed, fully desiccated then lyophilized for 48 hours. Specimens were then
weighed and a wet weight to dry weight ratio calculated

90

. To prevent introduction of

erroneous fluid to this measurement wet to dry ratios were not performed on subjects
for whom BALF had been collected.
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2.2.12 Non-Ventilated Controls: Measurements of each experimental variable except
for pulmonary biomechanics was performed on non-ventilated control animals.
2.2.13 Statistical Analysis: All quantitative experimental studies were performed with a
minimum of n=3 however the values vary between individual groups experiments. A
more in-depth explanation of the variation in N values is given in the supplement.
Survival statistics were performed with Kaplan-Meyer estimation. For wet to dry data
analysis two way ANOVA was used to establish pairwise differences across age and
one way ANOVA with Tukey tests were used to establish within group differences. All
other statistics were performed using two way ANOVA. P values of <0.05 were
considered significant. We used GraphPad Prism 5 statistical analysis software.
2.3.0 Results
2.3.1 Four Hour High Fluid Survival Rate: 4hr survival curve for old subjects
ventilated with HVT and high fluid support was statistically significantly lower than that
observed in all other groups (figure 20). In all, only four of twelve old HVT subjects
survived the 4Hr duration of their respective ventilations. By contrast, only one old HVT
subject on the low fluid support protocol died during mechanical ventilation.
Additionally, only one old LVT subject and one young LVT subject died during
mechanical ventilation. No young HVT subjects died during mechanical ventilation
(figure 20).
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Figure 20: 4Hr Survival Rate. Survival rate in the Old HVT-HF group was significantly less than all other
groups. Data is presented as survival percentage N = 10 for Young LVT-HF, 10 for Young HVT-HF, 3 for
Young HVT-LF, 7 for Old LVT-HF, 12 for Old HVT-HF, 8 for Old HVT-LF ***p<0.001.

2.3.2 One Hour Lung Wet to Dry Ratios: Wet to dry ratios for each of the 1hr
ventilation groups were measured (figure 21A). A statistically significant group-wise
difference across age was observed with the older murine groups exhibiting significantly
greater wet to dry ratios than the young. The wet to dry ratios for young HVT subjects
receiving high fluid protocol was significantly greater than that observed in the young
non-ventilated group (figure 21A). The wet to dry ratio of old HVT subjects receiving
low fluid protocol was significantly lower than that observed in the old HVT subjects who
received high fluid protocol and the old non-ventilated group (figure 21A).
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Figure 21: A. 1Hr Lung Wet to Dry Ratios. There was a group wise statistically significant difference
across age with old groups having significantly greater lung wet to dry ratio than young. The Young HVTHF group was significantly greater than in the Young Non-Ventilated group. The Old HVT-LF group was
significantly less than in all other old groups respectively. Data are presented as mean +/- st.dev N = 4
for Young Non-Vent, 4 for Young HVT-HF, 4 for Young HVT-LF, 4 for Old Non-Vent, 4 for Old HVT-HF,
5 for Old HVT-LF. B. 4Hr Lavage Protein Concentration. The Old HVT-HF group concentration was
significantly greater than that of all other old groups respectively. N = 4 for Young Non-Vent, 4 for Young
LVT-HF, 7 for Young HVT-HF, 3 for Young HVT-LF, 4 for Old Non-Vent, 4 for Old LVT-HF, 4 for Old HVTHF, 5 for Old HVT-LF *p<0.05.

2.3.3 Four Hour Bronchoalveolar Lavage Fluid Protein Concentration: BAL fluid
protein concentrations were measured for each animal subject surviving 4hr ventilation
(figure 21B). There was not a statistically significant group wise difference in lavage
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protein concentration across age. Within the old group, the lavage protein
concentration of subjects ventilated with HVT and high fluid support was significantly
greater than that of all other old groups respectively. Similar trends were seen between
the young groups but none reached statistical significance.

Table 1: Cellularity in BALF. Data presented as absolute cell numbers in broncoalveolar lavage and as
cell differentials (percentage of counted cells). Monocyte differential < Young Non-Ventilated and Old
Non-Ventilated. Data are presented as mean +/- st.dev N=4 for Young Non-Vent, 3 for Young LVT –
HF, 6 for Young HVT – HF, 3 for Young HVT – LF, 6 for Old Non-Vent, 4 for Old LVT – HF, 4 for Old
HVT – HF, 5 for Old HVT – LF *p<0.05.

2.3.4 Bronchoalveolar Lavage Fluid Cytology: Cytological differentials were
measured on the BAL fluid of each subject surviving 4Hr ventilation (Table 1). The
monocyte differentials of Old HVT high fluid group were significantly greater than those
of both the Young Non-Ventilated and Old Non-Ventilated groups. No other statistically
significant differences were observed.
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Figure 22: A. Representative 4Hr PV Loop for a Young LVT-HF subject. B. Representative 4Hr
PV Loop for an Old LVT-HF subject. C. Representative 4Hr PV Loop for a Young HVT-HF subject.
D. Representative 4Hr PV Loop for an Old HVT-HF subject.

2.3.5 PV Loop Hysteresis: PV loops were generated hourly using the Flexivent
software (Scireq) for each surviving animal subject. Representative PV loops are shown
in figure 22. The hysteresis values of each group were normalized with their respective
0hr values (figure 23). There was a group wise difference across age with old groups
having significantly greater 1Hr PV loop hysteresis than young. 1Hr PV loop hysteresis
of Old HVT high fluid group was significantly greater than that of the Old HVT low fluid
group (figure 23A). The 4Hr PV loop hysteresis of the old HVT high fluid was
significantly greater than that of both the old LVT high fluid and old HVT low fluid groups
(figure 23B). Similar trends were seen between the young groups but none reached
statistical significance.
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Figure 23: A. 1Hr PV Loop Hysteresis. Hysteresis in the Old HVT-HF group was significantly
greater than Young HVT-HF and Old HVT-LF groups. Data are presented as mean +/- st.dev N=7
for Young HVT-HF, 7 for Young HVT-LF, 9 for Old HVT-HF, 12 for Old HVT-LF. B. 4Hr PV Loop
Hysteresis. Hysteresis of the Old HVT-HF group was greater than that of the Old LVT-HF and Old
HVT-LF groups. N=5 for Young LVT-HF, 6 for Young HVT-HF, 3 for Young HVT-LF, 5 for Old
LVT-HF, 4 for Old HVT-HF, 5 for Old HVT-LF *p<0.05 **p<0.01.
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Figure 24: A. 1Hr Lung Compliance. There was a significant group wise across age with the old
groups having a greater compliance than the young. 1Hr lung compliance in the Old HVT-HF
group was significantly greater that of the Old HVT-LF group. Data are presented as mean +/st.dev N=11 for Young HVT – HF, 4 for Young HVT – LF, 14 for Old HVT – HF, 7 for Old HVT – LF.
B. 1Hr Total Lung Capacity. There was a significant group wise difference across age with the old
groups having a greater TLC than young. 1Hr TLC in the Old HVT-HF group was significantly
greater that of the Old HVT-LF group. N=4 for Young HVT – HF, 4 for Young HVT – LF, 14 for Old
HVT – HF, 14 for Old HVT – LF. C. 4Hr Lung Compliance. There was a significant group wise
difference across age with the old groups having greater lung compliance than the young. 4Hr lung
compliance in the Old HVT-HF group was significantly greater that of the Old 0Hr and Old HVT-LF
groups. N=11 for 0Hr Young, 7 for Young LVT – HF, 8 for Young HVT – HF, 3 for Young HVT –
LF, 16 for 0Hr Old, 6 for Old LVT – HF, 4 for Old HVT – HF, 6 for Old HVT – LF. D. 4Hr Total Lung
Capacity. There was a significant group wise difference across age with the old groups having a
greater TLC than young. 4Hr TLC in the Old HVT-HF group was significantly greater that of the Old
HVT-LF group. N=11 for 0Hr Young, 7 for Young LVT – HF, 9 for Young HVT – HF, 3 for Young
HVT – LF, 16 for 0Hr Old, 6 for Old LVT – HF, 4 for Old HVT – HF, 6 for Old HVT – LF, *p<0.05
**p<0.01 ***p<0.001 ****p<0.0001.
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2.3.6 Lung Compliance: Lung compliance was measured hourly using the Flexivent
software (Scireq) for each surviving animal subject (figure 24). There was a significant
group wise difference across age of both the 1Hr and 4Hr lung compliance with old
groups having greater compliance than young. (figure 24 A, C). The 1Hr lung
compliance of the old HVT high fluid group was significantly greater than that of the
HVT low fluid group (figure 24A). The 4Hr lung compliance of the old HVT high fluid
group was greater than that of the old HVT low fluid group (figure 24C). There was a
strong non-significant trend with the old 4Hr HVT high fluid groups having a greater
mean than the old 4Hr LVT low fluid group.
2.3.7 Total Lung Capacity: Total Lung Capacity (TLC) was measured hourly using the
Flexivent software (Scireq) for each surviving animal subject (figure 24). There was a
statistically significant group wise difference across age of both the 1Hr and 4Hr TLC
with the old groups having greater TLC than young (figure 24 B, D). The 1Hr TLC of the
old HVT high fluid group was significantly greater than that of the HVT low fluid group
(figure 24B). The 4Hr TLC of the old HVT high fluid group was significantly greater than
that of the old HVT low fluid group (figure 24D). There was a strong non-significant
trend with the old 4Hr HVT high fluid group having a greater mean than the old 4Hr LVT
high fluid group.
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Figure 25: A, B, C, D, E, F. Representative 4Hr histological H&E images of A. Young LVT-HF,
B. Young HVT-HF, C. Young HVT-LF, D. Old LVT-HF, E. Old HVT-HF, and F. Old HVT-LF lung
sections respectively.

2.3.8 Airspace Enlargement: Representative histological images of lung stained with
H&E of both young and old animal subjects ventilated with HV or LV are presented in
figure 25A-D. Airspace enlargement and an increased infiltration of erythrocytes could
clearly be seen in images corresponding to both increased age and HVT ventilation.
Low fluid protocols visually attenuated these effects. Airspace enlargement was
quantified and calculated for each subject reaching 4hrs of mechanical ventilation.
There was a significant group wise difference in airspace enlargement across age with
old groups having a greater value that young. Airspace enlargement of old subjects
ventilated with HVT and high fluid was significantly greater than that of all other groups
(figure 26).
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Figure 26: Airspace Enlargement. There was a statistically significant groupwise difference across
age with old groups having significantly greater enlargement than young. Enlargement was greater in
the Old HVT-HF group than in all others. Data are presented as mean +/- st.dev N = 3 for Young
Non-Vent, 6 for Young LVT-HF, 6 for Young HVT-HF, 3 for Young HVT-LF, 3 for Old Non-Vent, 3 for
Old LVT-HF, 4 for Old HVT-HF, 3 for Old HVT-LF **p<0.01.

2.4 Discussion

The first aim of this study was to establish that older mouse subjects when subjected to
HVT MV exhibit an increased severity of ventilator-induced lung injury as was recently
reported in an aging rat model 59. Wilson et al established that significant stretch
induced lung injury in young healthy mice requires mechanical ventilation with tidal
volumes approaching 40mg/ml 91. Consequently most models of VILI use similarly high
(>30mg/ml) VT and/or inspiratory pressures to induce injury. These settings however
are generally considered significantly higher than those used in the clinical management
of patients 91,92. Setzer et al demonstrated that the increased sensitivity of the aging rat
lung to mechanical ventilation allowed their group to achieve significant VILI with tidal
volumes of 16-24mg/kg 59. So while a tidal volume of 40mg/kg may be more
conventionally referred to as “High Tidal Volume”, our HVT protocol is both sufficient to
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cause ventilator induced injury and mortality in our older subjects and is closer to clinical
relevance than other higher HVT standards.
Each of our experimental measures demonstrates a significant pattern of ageassociated increase in inflammation and injury. Our second aim was to determine
whether administration of a conservative fluid management strategy alone would
attenuate these effects. While fluid management has long been an important issue in
clinical medicine; the role of fluid management on the development and outcome of VILI
had yet to be quantitatively studied in-vivo. The addition of conservative fluid support to
our HVT ventilation protocol attenuated VILI and significantly decreased the mortality
rate in older subjects.
Patient mortality is the gravest complication of mechanical ventilation. In our
study neither advanced age nor HVT ventilation alone significantly increased subject
mortality. Only with the combination of advanced age and HVT did our study yield a
profound decrease in our subjects’ survival (figure 18). Considering the epidemiology of
VILI the experimental validation of the age-associated increase in ventilator mortality is
already of paramount importance. Potentially even more meaningful however was that
we were able to completely attenuate the age-associated increase in our subject’s HVT
mortality with the administration of a low fluid protocol. Pulmonary edema, pulmonary
mechanics, lung histology, and BALF cytology data all give a strong testimony that the
resolution of VILI induced edema itself is a primary mechanism through which this low
fluid protocol is able to enact such a dramatically protective effect.
Pulmonary edema is a hallmark of VILI and the severity and susceptibility to
pulmonary edema increases with age

50,93–95

. Some of the driving forces behind
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development and progression of pulmonary edema both in general and in VILI are
increases in pulmonary intravascular pressure, decreased epithelial barrier
integrity/increased permeability, and increased local and systemic inflammatory
cytokine presence. Since conservative fluid strategies decease intravascular pressure,
it is not surprising that a body of data has emerged linking them to decreased
pulmonary edema and increased survival rates both in animal and human studies of
ARDS 88,95,96. However, liberal fluid management strategies are not wholly without
merit. Liberal fluid resuscitation is known to have positive effects on blood pressure and
other hemodynamic factors in human studies 95.
The role of aquaporin channels in pulmonary fluid clearance and how they my
specifically interact with VILI, aging, and edema is complicated at the very least.
Zhongguo et al showed that aquaporin channel 1 and 5 (AQP1& AQP5) expression
decreases in rats with hyperoxia induced lung injury and correlates with increases in
pulmonary edema. And although low tidal volume mechanical ventilation was not found
to increase alveolar barrier permeability or pulmonary edema in rats, it was shown to
increase AQP1 and AQP5 expression. Age is known to be a predictive factor in the
incidence and severity of pulmonary edema 29,97. Zhang et al showed that aging lungs
exhibit decreased aquaporin channel expression
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. Additionally, it is known that age-

associated changes in lung physiology increase susceptibility to and severity of both
VILI and pulmonary edema independently during mechanical ventilation. In the present
study, we hypothesized that the negative synergy of the age-associated increases
allows them to be powerful regulators of the age-associated increases in ventilator
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mortality rates observed both in animal models and in older patients who are
mechanically ventilated.
In our 1hr ventilations we found significant increases in lung wet to dry
ratiosventilator-associated with both advanced age and liberal fluid support. These
results support the general finding that age increases the incidence and severity of
edema 59,94. They also demonstrate our experimental model’s ability to induce
ventilator-associated pulmonary edema with HVT mechanical ventilation and
subsequently attenuate it through conservative fluid administration alone.
Increased lavage protein concentration is a general marker of lung injury and of
enhanced pulmonary permeability and edema98. In our 4hr subjects, lavage protein
concentration was significantly increased by HVT ventilation. Importantly, old subjects
on low fluid protocol exhibited near complete attenuation of the high protein containing
BAL fluid produced by HVT ventilation. As with our 1hr ventilation results, these data
establish our ability to use HVT mechanical ventilation and conservative fluid
management both induce and ablate pulmonary edema respectively.
Pulmonary disease changes the physiology of the lungs, which manifests as
changes in respiratory mechanics. Therefore, measurement of respiratory mechanics
allows a clinician to monitor closely the course of pulmonary disease 99. The area of the
pressure volume loop (i.e., the hysteresis) is the geometric representation of the energy
lost during each breath cycle. Increased hysteresis is indicative of compromised lung
mechanics function and is a hallmark of aging and various lung pathologies

25,100

. The

one hour PV-Loop data demonstrated that conservative fluid support in the old HVT
subjects attenuated age-related increase in MV induced pulmonary mechanical
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disruption. The success of these conservative fluid strategies in decreasing the severity
of pulmonary edema and improving pulmonary mechanics in our 1Hr HVT subjects
precipitated us to confidently apply our conservative fluid protocols to a group of old
subjects being mechanically ventilated for 4hrs in hopes of increasing their survival rate.
Predictably the four hour PV-Loop data showed an even more significant pattern of
disruption and resolution of pulmonary mechanics with the administration of liberal and
conservative fluid protocols respectively in our old murine subjects. In young subjects
we saw a similar pattern but none of hysteresis differences reached statistical
significance.
In addition to their hysteresis values, the PV loops also contain information in the
shape of their ascending limb. In figure 22, we see that while the shapes of the PV
loops of young LVT and HVT and old LVT subjects vary only minimally over time, the
old HVT loops splay strongly to the left. This represents an increasing rise in pulmonary
compliance over time. Increased lung compliance is a hallmark of the age-associated
decline in lung mechanics and of many pathological conditions
considered to significantly change with age

53,58,101

. TLC is not

. It is generally known that this effect
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results from the almost perfect balance between the age-associated increase in lung
compliance, the decrease in respiratory muscle tone, and the increase in chest wall
stiffness24. However, in our experiments, the Flexivent system calculates TLC based
upon the volume of air required to inflate the lung to a specified pressure. Therefore,
the age-associated loss of muscle tone does not affect the TLC measurements.
Consequently, we expect the loss of lung compliance to dominate these measurements
and expect to see TLC measurements taken with the Flexivent system to increase with
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age. Furthermore, certain types of lung injury (e.g., emphysema) increase lung
compliance, and thus, they further increase total lung capacity as measured by our
Flexivent system103.
Both age and injury related increases in these pulmonary mechanical measures
were observed in our study. The significantly increased 0hr lung compliance and total
lung capacity in old mice demonstrates the predicted age-associated changes in
pulmonary physiology and mechanics. The strong trend toward increased mean values
of both lung compliance and TLC observed in HVT vs LVT ventilator protocols seen in
our older subjects therefore notable as well. Even more striking is that both lung
compliance and TLC values are significantly decreased in older HVT subjects when
treated with conservative fluid protocols. These findings demonstrate that HVT
ventilation promotes greater injury compared to LVT ventilation in old animal subjects,
and that this injury can be attenuated with a low fluid protocol alone.
Collectively these mechanics data paint a picture of an aging lung whose
mechanical dysfunction is a downstream effect of the loss of elasticity and subsequent
increase in compliance. This is in agreement with the known age-associated decrease
in elastin fibers of the lung parenchyma104. However, it must be noted that in general
having increased pulmonary edema classically decreases lung compliance. This would
seem to be in opposition to the pattern we observed of increasing lung compliance with
injury. However, VILI induced changes in the lung parenchyma do operate in the
direction of increasing lung compliances. In our histological analysis, we found a
qualitative decrease in the presence and quality of elastin in older mice (Supplemental
Figure).
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We further investigated our model’s effect on lung parenchyma destruction
through measurement of ventilation-induced alveolar airspace enlargement. Increased
airspace enlargement values areventilator-associated with both increased age and
pathophysiological conditions such as emphysema and VILI 105,106. In our case, the
differences we observed in the airspace enlargement values for the experimental
groups represent the extent of the alveolar barrier injury/destruction resulting from
mechanical ventilation. Just as with our mechanics, edema, and cytology data, we
expected to observe a group-wise difference in the airspace enlargement values across
age, with older mice exhibiting greater airspace enlargement values than younger mice.
Further, we expected to see significant increases in airspace enlargement values of
HVT subjects over non-ventilated controls and LVT subjects. Our data not only
showed both of these patterns, but additionally there was a significant interaction effect
of increased airspace enlargement when advanced age combined with HVT ventilation.
These pro-pulmonary compliance changes in the lung parenchyma work in opposition to
the anti-compliant mechanics classically observed in an edematous lung. The fact we
seen an increasing compliance in our most injured subjects despite their increasingly
edematous lungs suggests that the mechanical effect of the injury/destruction of the
parenchyma has a more profound impact on the overall lung mechanics than the
edema.
Our cytological analysis of BAL fluid demonstrates a pattern of inflammatory cell
recruitment that further validates our experimental model of VILI in aging mice.
Recruitment of lymphocytes, neutrophils, basophils, and eosinophils to the site of an
injury is part of the normal immuno-inflammatory and wound healing response

40,107

.
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Literature, experimental data, and our research lead us to conclude that age-related
increases in the severity of VILI should amplify this damage-associated pattern both
systemically and in the microenvironment of the lung

57,59,90

. However, several studies

have found little or no differences in BAL fluid cell count ratios between young and old
healthy mice 96,103,108. For this reason, we expected that we would only see significant
differences in differential cell counts between ventilation control and HVT subjects and
that furthermore; this pattern would be more exaggerated in the old vs. the young
subjects.
As expected, our cytological analysis failed to yield significant differences
between young and old control groups. The only significant differences we observed
were between old subjects ventilated with HVT and young and old control groups.
These cytology data support our hypothesis by demonstrating the synergistic effect of
advanced age and HVT ventilation on lung inflammation and injury. This ageassociated increase in ventilator –induced pulmonary “biotrauma” is decidedly “midstream” in the VILI process. Alveolar epithelial cell barrier function is known to be
disrupted by inflammatory cytokines. Increased pro-inflammatory cytokine levels in the
lung promote disruption of the lung’s barrier function thus resulting in enhanced
permeability and development of pulmonary edema.
Thus, the work reported here demonstrates that a low fluid support strategy
alone can reverse the age-associated increases in the 4hr hour mortality rate of older
subjects ventilated with HVT. The significantly important finding arising from this work is
that development of pulmonary edema has both deleterious up and down stream
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impacts on the development of VILI. Further, we have identified the crucial role
conservative fluid administration has in diminishing lung edema and the severity of VILI.
In conclusion, our findings suggest that the age-associated increase in VILIinduced pulmonary edema is not simply a downstream marker of injury but also a
mechanism for further injury and increased mortality. And while already known that
conservative fluid support strategies give favorable outcomes to patients with ARDS,
this is the first evidence that these strategies also attenuate VILI and its age-associated
increase in severity. Considering the relative lack of preventative treatments for VILI
and the age-associated increases in injury and death, the development of agedependent fluid support strategies may be of critical importance in increasing the
survival rate of elderly ventilator patients.
2.5 Limitations
The volume parameter of mechanical ventilations is generally determined by the
application of a ratio between tidal volume and patient weight. For this purpose it is
often the preferred clinical practice to use a calculation of the patient’s ideal body weight
instead of their actual weight as to not over or under ventilate under or overweight
patients. This is of particular importance in our study as 20 month old mice are reliably
~30% more massive than their younger counterparts. If not accounted for, this would
result in the lungs of the older subjects being systematically inflated to larger volumes
based on their size than those of their younger counterparts. However, it has also been
noted that while the lungs of the older mice may not be larger than those of the young
adult mice, the increased mass of the older mice does correlate with an increased
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circulatory volume. Therefore while the weight-adjusted tidal volume may provide a
lung volume normalized tidal volume, the older mice are receiving a lower tidal volume
relative to their circulatory volume. This is of course not different from how overweight
human patients may be ventilated but is still a potentially important limitation to
consider.
3.0
The Role of ER Stress and Aging in an In Vitro Models of Ventilator Induced Lung
Injury
3.1.0 Introduction
Ventilator induced lung injury is initiated by mechanical insult to the lung. However, it is
the systemic release of cytokines that if unabated develops into systemic inflammatory
response syndrome (SIRS). SIRS in turn promotes multiple organ system dysfunction
(MODS) which is the primary cause of death in VILI patients 109.
The majority of patients requiring mechanical ventilation are over the age of 65
and advanced age is known to increase the severity of VILI and in-hospital mortality
rates29. However, the mechanisms which predispose aging ventilator patients to
increased severity of VILI and ventilator-associated mortality rates are not fully
understood. Age-associated pathological changes in lung mechanics are well known
and have been implicated in the severity of VILI but the relationship has not yet been
fully elucidated. Additionally, the role of the aging alveolar epithelium in VILI is wholly
unknown at this time.
There is however evidence to suggest that there may be a causal link between
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epithelial cell aging and the age-associated increase in the severity of VILI. In general,
advanced age is also known to promote an increasingly dysregulated innate
immune/inflammatory response to injury with an overall shift towards a proinflammatory
state57,58. Additionally, mechanical stretch alone has been shown to cause injury and
promote a proinflammatory cascade in multiple cell lines40,110,111. Mechanical stretch of
lung epithelial cells has been shown to increase cell injury and death, increase
apoptosis, increase acidification and bacterial growth, and increase general
inflammatory response including gene expression and release of IL-6 and IL-8 112.
Additionally, mechanical stretch compromises epithelial barrier integrity by damaging
the plasma membrane, increasing barrier permeability, and decreasing overall barrier
function113–116.
Mechanical stretch has also been shown to increase oxidative stress and
promote epithelial to mesenchymal transition in alveolar epithelial

. However,

113,114,117

to date no research has been done to establish the effect of aging on mechanical
stretch induced injury and inflammation in pulmonary epithelial cells. Age alone is also
known to increase inflammation and injury to various types of insult through the
senescence-associated secretory phenotype (SASP) pathway 118,119. Aging has also
been shown to promote chronic inflammation in the murine lung115. Aging has also
been shown to promote damage and inhibit repair in the lung epithelium following insult
with influenza120. We hypothesize that aged lung epithelia respond to mechanical
stretch with a dysregulated inflammatory cytokine production which may be triggered by
endoplasmic reticulum (ER) stress and the unfolded protein response (UPR).
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The endoplasmic reticulum is a multifunctional organelle responsible for lipid
biosynthesis, calcium storage, and protein folding and processing 64. Because of the
innate inefficiency of protein folding as many as 30% of proteins never acquire their fully
folded conformation121. The unfolded protein response (UPR) suppresses aggregation
of these improperly folded proteins through three independent pathway which inhibiting
protein synthesis, chaperone nascent or unfolded proteins, and discern then transport
them through a degradation pathway before they can aggregate 122. However, if the
UPR is unable to restore protein homeostasis inside the ER and resolve the
aggregation of misfolded proteins, the apoptotic arms of the UPR is activated and
apoptosis is accordingly promoted. Thus prolonged unresolved ER stress can cause
accumulation of misfolded proteins, disruption of cellular functions, apoptosis, and has
been shown to play a key role in many chronic inflammatory disease states.
Specifically in alveolar epithelial cells, ER stress has been shown to regulate apoptosis,
idiopathic pulmonary fibrosis, and epithelial to mesenchymal transition 123.
The UPR is also known to become increasingly dysregulated with age 124. There
is a general age-associated increase in the occurrence of protein misfolding and
accumulation. There is also a downregulation of the three non-apoptotic arms of the
UPR while the pro-apoptotic arm is semi-independently upregulated125,126.
Unsurprisingly ER stress is implicated as a promoter of many pathological disease
states associated with aging72. Additionally, ER stress has been implicated in the ageassociated increase in pulmonary fibrosis127.
However, despite the clear path the VILI must take through systemic
inflammation to claim MODS at its main cause of death, there have been no studies to
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date of the role of ER stress in VILI. Therefore unsurprisingly despite the well known
the role of age-associated ER stress in many inflammatory disease states, VILI is not
among them.
To investigate this relationship we isolated and cultured primary alveolar epithelial ATII
cells (ATIIs) from young and old murine subjects. These cells were treated with 24h of
cyclic mechanical stretch to promote mechanical stretch induced injury. We measured
age-associated differences in ER stress response, cell injury/inflammation, and
apoptosis. To help establish the position of ER stress relative to these measures of
inflammation and injury in the VILI pathway we also inhibited ER stress using known ER
stress inhibitor 4-phenylbutyrate (4-PBA)128. 4-PBA is already in use as a successful
treatment for systemic inflammatory diseases such as diabetes 129. So in addition to
determining location of ER stress in cellular inflammatory VILI cascade we are also
evaluating a critically needed treatment for VILI in aging patients.
3.2.0 Methods
3.2.1 ATII cell isolation and culture: For this project we harvested, isolated, and
cultured ATII primary alveolar epithelial cells from young (8 week) and old (20 months)
C57BL/6J wild type mice (WT) using previously cited methods [40]. Once cells were
isolated we suspend them in Bronchial Epithelial Cell Growth Media (BEGM, Lonza)
with all included supplemented added except hydrocortisone and supplemented with 10
ng/ml KGF (keratinocyte growth factor, PeproTech). Cells were then plated on collagen
I coated 6-well silicone bottomed plates (Flexcell).
3.2.2 ATII Cellular Phenotyping: Cellular phenotyping was used to validate isolation
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protocols. 48 hours after isolation both young and old cells were phenotyped using
positive surfactant protein C (Abcam) primary antibody followed by AlexaFluor 488
secondary and counter stained with prolong gold anti-fade reagent with DAPI nuclear
stain. A random sampling of images were qualitatively evaluated to pure ATII
population in culture.
3.2.3 CHOP Immunofluorescence: Old and young mice were ventilated for 4 hours
with ventilation protocol cited in chapter 2. After 4 hour ventilation subjects were
sacrificed, lungs were extracted and fixed, and serological lung sections were obtained
using histology methods cited in chapter 2. Slides were then stained with a primary
antibody to CHOP (Cell Signaling, 1:1000) followed by AlexaFluor 594 secondary
counter stained with DAPI nuclear stain, and imaged using an Olympus IX71
Microscope (Olympus).
3.2.4 Cell Stretch: After a 48 hour incubation we used the Flexcell Tension Plus
System (Flexcell incto cyclically equibiaxially stretch the cells to and 15% change in
surface area for durations of 4, 24, 48 and 96 hours. This stretch percentage
corresponds to the stretch seen by ATII cells during injurious MV. Statically cultured
ATII cells were used as controls. After cells were stretch treated, we collected the
media and mRNA from each well.
3.2.5 ER Stress Inhibition: One hour prior to mechanical stretch each well received
either 100ul vehicle (phosphate buffered saline; PBS) or 10 mmol/L sodium 4phenylbultyrate (PBA) (Calbiochem, San Diego, CA) in 100ul PBS.
3.2.6 MTT Assay: MTT assays (Roche) were performed to measure net metabolic
processing. These results can be used to infer relative rates of cellular or cytostatic
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activity. Decreases in MTT values represent increases in cell injury and/or death.
Increases in MTT values indicate the shift of the ATII cells from a resting to proliferative
state.
3.2.7 mRNA Analysis: We collected mRNA from each treatment group (RNeasy Mini
Kit, Qiagen), purified the mRNA and used a standard RT kit (Biorad) to convert the RNA
to CDNA. We used custom QPCR plates (Biorad) to perform QPCR analysis on 27
inflammatory genes of interest (Aimp1, B2m, Ccl12, Ccl2, Ccl20, Ccl3,Ccl4, Ccl6, Ccl7,
Ccl9, Ccr1, Csf1, Cxcl12, Cxcl15, Cxcl5, Gusb, HSP90ab1, Il10rb, Il15, Il1a, Il1r1, Il2rg,
Il6st, Nampt, Sgpp1, Tnfrsf11b, Vegfa).
3.2.8 Media Protein Concentration: We performed BCA assays (Pierce) on all
collected cell media samples to measure cell media protein concentrations.
3.2.9 Inflammatory Mediator Analysis: We measured the concentrations of select
inflammatory cytokines of interest in the collected cell media of each experimental group
using 10 protein (IL-1a, IL-1b, IL-4, IL-6, IL-10, IL-12, MCP-1, MIP-1a, RANTES, TNF-a)
custom Bio-Plex ELISAs (BioRad). Values were normalized to each samples protein
concentration levels.
3.3.0 Results
3.3.1 Phenotyping: In both young and old ATII cells a random sampling of images
confirmed positive staining for surfactant protein C (figure 27).
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Figure 27: Representative 20X surfactant C images of A. Old 24Hr and B.
Young 24Hr cells. Green are pro-SPC positive cells, blue are nuclei stained with
DAPI

A

B

C

D

Figure 28: Representative 20X 4Hr histological CHOP images of A. Young LVT-HF, B. Old LVT-HF, C.
Young HVT-HF, D. Old HVT-HF lung sections. Yellow are CHOP positive cells, blue are nuclei stained with
DAPI
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3.3.2 CHOP Staining: Representative CHOP staining of lungs tissue displayed both a
general age-associated and ventilator protocol associated difference in CHOP
expression (figure 28). Advanced age and HVT ventilation increased CHOP expression
both independently and in combination.
A

B

Figure 29: Normalized MTT absorbance values. A. MTT values for Young 5% 24hr and 96hr groups
were significantly higher than static controls. MTT Value for Young 15% 4hr group was significantly
higher than static control, B. MTT value for Old 5% 96hr group was significantly greater than static
control. MTT value for old 15% 96hr was significantly lower than static control. Data presented as mean
+/- st.dev n=3 *p<0.05

3.3.3 MTT Assay: In Young 5% stretch groups 24Hr and 96Hr each had significantly
higher MTT values than static controls. In Young 15% stretch only 4Hr group had
significantly higher MTT value than static control (figure 27A). In Old 5% stretch groups
only 96Hr group had significantly higher MTT value than static control. In Old 15%
stretch groups only 96Hr had significantly lower MTT value than static control (figure
29B).
3.3.4 Inflammatory Gene Expression: ER stress-associated Chop and ATF4 gene
expression was significantly greater in Old 24Hr stretch ER control groups compared to
every other group (figure 30). No other relationships were significant. However, Chop
and ATF4 gene expression in Old 24Hr stretch ER Control group showed an increase in
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mean compared to Old 24Hr static ER control. Additionally, Chop and ATF4 gene
expression in Old static ER inhibited groups showed a decrease in compared to Old
24Hr static ER control but the trend was not significant.

A

B

Figure 30: Age, stretch, and ER inhibitor induced inflammatory gene expression. A,B. Old 24Hr
Static ER Control, Old 24Hr Stretch ER Control, Old 24Hr Static ER Inhibited, Old 24Hr Stretch
ER Inhibited, normalized to Old 24Hr Static ER Control. Columns are fold change differences in
gene expression. Data are presented as mean +/- st. deviation, n=3, *p<0.05.

Advanced age alone and advanced age combined with mechanical stretch were
associated with general increases in inflammatory gene expression (figure 31A).
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Figure 31: Age and stretch induced inflammatory gene expression. A. Young 24Hr Static, Old 24Hr
Static, Young 24Hr Stretch, Old 24Hr Stretch normalized to Young 24Hr Static. B. Young 24Hr Static
and Old 24Hr Static normalized to Young 24Hr Static. Columns are fold change differences in gene
expression. Data are presented as mean +/- st. deviation, n=3.
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Advanced age alone significantly increased the gene expression of Ccl6, Ccl9, Ccr1,
Il10rb, and Nambt in statically cultured old VS young cells (figure 31B and 32A).
A

B

Figure 32: Age and stretch induced inflammatory gene expression. A. Young 24Hr Static and
Old 24Hr Static normalized to Young 24Hr Static. B. Young 24Hr Static and Young 24Hr Stretch
normalized to Young 24Hr Static. Columns are fold change differences in gene expression. Data
are presented as mean +/- st. deviation, n=3, *p<0.05.

80

Mechanical stretch alone did not increase the expression of any inflammatory genes
measured in young cell cells treated with 24Hr 15% stretch VS those statically cultured
(figure gene 32B).
A

B

Figure 33: Age and stretch induced inflammatory gene expression. A,B. Old 24Hr Static and Old
24Hr Stretch normalized to Old 24Hr Static. Columns are fold change differences in gene expression.
Data are presented as mean +/- st. deviation, n=3, *p<0.05.
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Mechanical stretch alone increased gene expression of B2m, Ccl4, Csf1, and Il2rg in
old cells treated with 24Hr 15% stretch VS old statically cultured cells (figure 33 A, B).
A

B

Figure 34: Age and stretch induced inflammatory gene expression. A,B. Young 24Hr Stretch and
Old 24Hr Stretch normalized to Young 24Hr Stretch. Columns are fold change differences in gene
expression. Data are presented as mean +/- st. deviation, n=3, *p<0.05.
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Old cells treated with 24Hr 15% mechanical stretch had significantly increased
expression of B2m, Ccl2, Ccl3, Ccl4 Ccl7, Ccl6, Ccl9, Ccsf1, Cxcl15, Il1a and Nampt
compared to similarly treated young cells (figure 32A, B).
A

B

Figure 35: Age and stretch induced inflammatory gene expression. A,B. Old 24Hr Stretch ER Control
and Old 24Hr Stretch ER Inhibited normalized to Old 24Hr Stretch ER Control. Columns are fold change
differences in gene expression. Data are presented as mean +/- st. deviation, n=3, *p<0.05.

Old cells stretched and treated with 4-PBA exhibited significantly decreased expression
of B2m, Ccl6, Ccl7, Ccl9, Cxcl15, Nampt, Tnfrs11b and an increased expression of Il1a
relative to old cells stretched and treated with sham ER inhibition (figure 35 A, B).
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Treatment with 4-PBA significantly increased the expression of IL-1a and decreased
expression of IL-6 in both old cells treated with 24Hr 15% stretch and those statically
cultured (figure 36).
A

B

Figure 36: Age and stretch induced inflammatory gene expression. A,B. Old 24Hr Stretch ER
Control and Old 24Hr Stretch ER Inhibited normalized to Old 24Hr Stretch ER Control. Columns
are fold change differences in gene expression. Data are presented as mean +/- st. deviation,
n=3, *p<0.05.

3.3.5 Media protein concentration: Treatment with 4-PBA decreased the media
concentrations of inflammatory cytokines IL-6, MIP-1b, MCP-1, and Rantes in both old
cells treated with stretch and old statically cultured cells (figure 35 A,B,C,D). Treatment
with 4-PBA increased the media concentrations of inflammatory cytokines proteins IL1a,
IL-1b, IL-10 and MIP-1a in both old cells treated with stretch and old statically cultured
cells (figure 37z E,F,G,H).
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Figure 37: Cell media protein concentration. A,B,C,D,E,F,G,H. Old 24Hr Static ER Control, Old
24Hr Stretch ER Control, Old 24Hr Static ER Inhibited, Old 24Hr Stretch ER Inhibited. Data are
presented as mean +/- st. deviation, n=3, *p<0.05.

85

3.4.0 Discussion
Although the lung is undoubtedly one of the most physiologically complex organ
systems, it is unique in that its operation can be almost completely automated through
external stimulation long after the lung itself is too injured to function normally.
However, like any other system in a profound state of injury the lung produces a
predictable tirade of inflammatory cytokines27,41. And the lungs vascularity and
prominent position in the circulatory system guarantee that this inflammatory response
is efficiently exported to all of the major organs systems of the body.
Therefore while mechanical ventilation has the ability to force the physiologically
compromised lung to continue to oxygenate a patient’s body, in doing so the lung is
transformed into a powerful inflammation exporting engine. And because each other
organ system has a maximum amount of inflammation it can tolerate before
physiological failure, MODS rather than hypoxia is the leading cause of death
associated with VILI130.
We know that systemic inflammation itself can lead to ARDS which is
characterized by lung inflammation/injury, pulmonary edema, and compromised
pulmonary mechanics. Thus it is theoretically possible that mechanical ventilation itself
is not innately injurious to the lung but rather the circulation of cytokines caused by preexisting lung pathologies could lead to systemic inflammation which in turn leads to a
ventilator induced form of ARDS. However, there are multiple experimental examples
that demonstrate that systemic levels of cytokines in the circulatory system are
increased by the ventilation of a previously uninjured lung even with “protective”
ventilation protocols131–133. This clearly establishes that mechanical forces alone and
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the resultant deformations imparted to the lung during mechanical ventilation are
sufficient to cause an inflammatory response independent of other factors. This
combined with the relatively straightforward nature of measuring, describing, and
manipulating the mechanical forces associated with both spontaneous and mechanical
ventilation has made modification of ventilation protocols the obvious initial target for the
attenuation of VILI. The two most common modifications to ventilation protocols
associated with improved patient outcomes are decreased tidal volumes and the
inclusion of PEEP in the ventilation cycle134.
However, despite the success of these kinds of protocols in attenuating VILI,
mortality rates for ventilator patients is still extremely high. The physiological pathway
that leads these mechanical forces exerted on the lung to have MODS as their chief
cause of death necessarily travels through cellular and inflammatory processes. This
means that it is critical to pursue cellular therapeutic targets for VILI as well. Thus just
as the known mechanical changes associated with the aging lung immediately suggest
themselves as mechanism for increased susceptibility to VILI, an exploration of the MV
to MODS inflammatory pathway does the same. There is both a known increase in the
inflammatory known age-associated increase in the upregulation of ER stress may
further explain the age-associated increase in the severity of VILI and ventilatorassociated mortality rates.
Although there is a known increase in the severity of ER stress-associated
with age, the underlying mechanisms are not known at this time. To establish a link
between this age-associated ER stress and ventilator induced lung injury in a murine
model we began by staining lung sections from you young and old mechanically
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ventilated murine subjects for CHOP. A qualitative analysis of the alveolar CHOP
expression confirmed an elevated level of ER stress-associated with both advanced age
and HVT mechanical ventilation.
In order to confirm the role of this ER stress in the inflammatory VILI process we
next isolated the effects of age and mechanical both independently and in combination
on inflammation and injury. We accomplished this by isolating, culturing, and
mechanically stretching young and old ATII cells.
In statically cultured ATII cells we demonstrated that the there was a significant
increase in the expression of Ccl6, Ccl9, Ccr1, Il10rb, and Nampt with age. With the
exception of Il10rb, each of these cytokines are associated with an increased level of
inflammation in the lung which is not surprising owing to the known increase in systemic
inflammation-associated with advanced age. Ccr1 in particular is the receptor to Ccl3
(MIP-1a) which is known to be upregulated in ventilator induced lung injury.
Additionally, the blocking of Ccr1 has been shown to decrease lung damage and
neutrophilic infiltration caused by high-pressure ventilation in vivo 135.
There was however no significant increase in expression of these or any other
inflammatory genes we measured in our young mechanically stretched ATII groups
compared to young static groups. This is somewhat surprising. But when considering
the increase in proliferation associated with this group it is entirely possible that the
proliferative signaling of 15% cell stretch is not significant to substantially activate pro
inflammatory gene pathways in our ATII cells in a 24hr time frame. Multiple studies
have suggested that 15% stretch is insufficient to injure young alveolar epithelial
cells113,116.
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The old AT2 cells were much more sensitive to mechanical stretch. When
compared to the gene expression of young cells stretched cells the old cells showed a
significant increase in the expression of numerous inflammatory genes. Not surprisingly
they showed an increase in the expression of all of the inflammatory genes we saw
previously upregulated with age alone.
However, there were a host of pro-inflammatory genes upregulated with only with
the combination of age and stretch. These genes are B2m, Ccl2, Ccl3, Ccl4, Ccl7,
Cxcl15, IL1a, and IL6. B2m has long been recognized as a potential marker for
inflammation, but its role in that process has yet to be elucidated. Furthermore to date
no specific role for B2m within the lungs has been established

. This is important

136,137

to note, because B2m is utilized in many models as a housekeeping gene.
Ccl2 is critical to leukocyte recruitment in the lung as well as being a regulator of
numerous inflammatory disease states including ARDS, fibrosis, and cancer.

138–140

As described previously, we demonstrated an age-associated increase in Ccr1
indicating that the aging lung epithelium may already be primed to be more sensitive to
Ccl3 which is itself upregulated by mechanical stretch in old ATII cells. Ccl7 has been
shown to be a strong regulator of neutrophilic lung inflammation. Antibody
neutralization of CCL2 and CCL7 significantly reduced LPS-induced total leukocyte and
neutrophil accumulation in the lung alveolar lavage fluid of mice.
Ccl4 (MIP 1-b) is a macrophage inflammatory protein and is well established as a
regulator in pulmonary inflammation in host of pathophysiological disease states of the
lung141,142. Cxcl15 is a neutrophil recruiting chemokine that is located in many mucosal
organs including the gastrointestinal tracts, endocrine organs and adrenal glands.
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Cxcl15 is expressed so abundantly in the lung however that it is known as lungkine.
IL-1a in an inflammatory cytokine that operates as an early necrosis alarmin and
a juxtacrine signaling molecule143. IL-1a release from damaged epithelial cells is both
necessary and sufficient to trigger an inflammatory response in human lung
fibroblasts.144 Additionally, IL-1a is an upstream regulator of the senescence associated
secretory pathway and the release of IL-6 and IL-8143. And lastly IL-6 is a proinflammatory cytokine which is involved in a wide variety of inflammatory disease states
including VILI 145 and was significantly upregulated in our old stretched cells.
To establish the mechanistic role of ER stress in these age-associated increases
in mechanical stretch induced inflammatory gene expression we administered the ER
stress inhibitor 4-PBA. As stated previously the mechanism that increases the severity
of ER stress with age are currently unknown. However, we hypothesized that the
molecular chaperone 4-PBA would still attenuate ER stress in our aged cell model.
Our gene expression results generally validate this hypothesis. There were
many inflammatory genes down regulated by the administration of 4-PBA. Of particular
interest are the genes B2m, Ccl7, Cxcl15, IL-6. Each of these 4 inflammatory genes is
known to contribute to pathological inflammatory processes in the lung, each was
upregulated in the previous experiment with a combination of advanced age and
stretch, and each was successfully downregulated with the administration of ER stress
inhibitor 4-PBA alone.
Ccl6 and Ccl9 gene expression were both upregulated in old stretched cells VS
static old cells as well. And the gene expression of both were reduced with 4-PBA
treatment. However, since these were also both elevated in static old cells VS static
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young cells their role in mechanical stretch induced inflammation is less clear.
Tnfrsf11b was also downregulated by 4-PBA but the meaning is also less than
straightforward. Tnfrsf11b is a decoy receptor for Nf-kb and is thought to mainly
function as an inflammatory inhibitor. It is also known to play an important role in
inhibiting oseoclastogenesis but it’s role in the lung epithelium is unknown to date 146. It
is possible that is this gene is activated to attenuate inflammation then a 4-PBA induced
reduction in inflammation may have reduced upstream activation of Tnfrsf11b gene
expression.
Lastly and most puzzlingly, there was a 4-PBA induced increase in IL-1a
expression. IL-1a is known only as an inflammatory cytokine and has no known antiinflammatory roles that would suggest a reason why it and it alone would be
upregulated in old stretched cells treated with 4-PBA.
To further establish the translatability of these results into a novel in vivo target
for treatment of VILI we investigated the 4-PBA induced changes in concentrations of
inflammatory cytokines secreted into the cell media. These results revealed the
inhibition of the secretion of several different inflammatory cytokines. Furthermore the
patterns of changes are generally in good agreement with the with the corresponding
changes 4-PBA induced changes in gene expression.
IL-6, Ccl2 (MCP-1), Cc-l4 (MIP-1b), and RANTES media concentrations were all
significantly decreased with ER inhibition in both stretched and statically cultured ATII
cells. Of these RANTES is the only one not already discussed thus far. RANTES is
pro-inflammatory neutrophil recruiter implicated in multiple pathological pulmonary
inflammatory conditions including pulmonary fibrosis, lung cancer, and viral lung
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infections147–149. 4-PBA upregulated IL-10 media concentration in both stretched and
static old cells. IL-10 has a somewhat complex role in the pulmonary has an
inflammatory process but is primarily anti-inflammatory supporting results of the 4-PBA
as attenuating ER stress
Additionally, 4-PBA treatment upregulated media concentrations of both IL-1a
and IL-1b in stretched and statically cultured old cells. This result is internally consistent
with our findings regarding the upregulation of IL-1a and IL-1r1 gene expression. It
confirms that these gene expression results are not just anomalous gene results but
rather translate into a meaningful difference in the cytokine excretion into the cell media.
The meaning of this effect and how to integrate it with known inflammatory physiology is
however unclear.
And lastly, the media concentration of Ccl3 (MIP1a) is strongly upregulated in
media samples of both stretch and static old cells treated with 4-PBA. This result is
difficult to contextualize for two reasons. Firstly, this is the only protein secretion result
that seems to be at odds with our gene expression data. While 4-PBA decreased the
Ccl3 gene expression, it seems to have increased the secretion of Ccl3 cells into the
surrounding media. Additionally, there is not an easily forthcoming explanation based
on our current understanding of MIP-1a and MIP-1b for why there would be any single
chemical chaperone what would have the effect of simultaneously and promoting and
attenuating the excretions of these two cytokines respectively.
In summation with the exception of Ccl3 of effects of 4-PBA treatments on cell
media cytokine concentrations are in good agreement with the gene expression data.
And with the exception of an upregulation of IL-1a the gene expression data is in good
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agreement with our hypothesis that 4-PBA successfully attenuates the age-associated
stretch induced increase in inflammatory gene expression.
4.0.0
VitC treatment attenuates VILI induced pulmonary edema and partially normalized
pulmonary mechanics.
4.1.0 Introduction
The pulmonary system is unique in its design in that each incremental step towards its
most distal region sees a meaningful increase in the complexity of the mechanical,
molecular, and physiological environment7,24. This organizational facet of the
pulmonary systems owes in part to the exponential manner in which succeeding
generations decrease in size terminating with the alveolar sacs having a structure in the
micrometer range. Furthermore the contribution to the lungs primary function of gas
exchange exhibit a parallel asymmetry with the alveolar sacs hosting of 90% of all gas
exchange. Thus the alveolar barrier is at once one of the most complex, biologically
essential, difficult to observe, and consequently least well understood regions of the
body. Not surprisingly many pathophysiological conditions of the alveolar barrier are
poor elucidated as well.
Furthermore the molecular pathophysiological effects of aging have only begun
to be recognized and thoroughly studied relatively recently. Thus the effects of aging on
alveolar barrier function are at a time both of such critical importance and so
understudied that the American journal of physiology has put out a call for studies on
this topic. Since then there have been some studies conducted to establish the
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pathophysiology of senescent alveolar cell types and the aging extra cellular network
but few studies address the effect of aging on alveolar barrier integrity directly. In
addition to our investigation of the aging lung and its interaction with VILI, in this project
we are involved in an ongoing investigation of VitC as a possible treatment for VILI and
other lung pathologies.
VitC is an essential nutrient for humans and many other animal species which
means that prolonged VitC deficiency results in a myriad of serious health complications
and eventually results in death150. VitC has a number of vitamers including its reduced
form ascorbic acid (AscA) and its anion ascorbate 151. Most animals that require VitC
are able to fully meet their requirements by synthesizing VitC from glucose. Humans
and other primates however cannot synthesize VitC as a result of a loss of function in
the gene for the enzyme L-gulono-gamma-lactone oxidase (Gulo) which is required in
the terminal step of ascorbate synthesis. By contrast, mice and rats produce
endogenous VitC and maintain high levels of ascorbate in their tissues. This
complicates the translatability of VitC studies from mice and rats to humans. To
overcome this limitation C57BL/6J wild type mice (WT) with a homozygous knockout of
the crucial Gulo producing gene (gulo-/- mice) are often employed for VitC research152.
Additionally, (WT) mice with a knockout of senescence marker protein-30 (SMP30) are
unable to synthesize VitC and are useful for VitC research as well 153.
VitC has many known biological functions all of which originate from its chemical
activities as a 1- or 2-electron reducing agent for several antioxidants

. Specialized

151

cells throughout body can take up AscA through Na +-dependent ascorbate
cotransporters (SVCT1 and SVCT2). Most other cells take up VitC in its oxidized form
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(DHA) via facilitative glucose transporters154. VitC is also a known cofactor in at least 8
enzymatic reactions 7 of which are collagen synthesis reactions. As a result VitC’s
corresponding avitaminosis, scurvy, is characterized by a generally increase in
sensitivity to oxidative stress. Additionally, over time VitC deficiency promotes
malformation of collagen in many of the bodies tissues including the skin, gums,
cartilage, blood vessel walls, and lung parenchyma 150. These malformations can lead
to bruising, bleeding, and inhibited wound healing in all of these tissues.
In addition to the generalized effects, VitC deficiency is known to have multiple
pathogenic effects on the lung. VitC deficient gulo-/- mice have been experimentally
shown to have an increased lung pathology following infection with influenza 155. One
study also showed that by their third month of life VitC deficient SMP 30 knockout mice
showed an 82.2% decrease in collagen I mRNA and the development of emphysema
(21.6% increase of mean linear intercepts (MLI) and 42.7% increase of destructive
index measured as described by Koike et al156).
VitC levels have been shown to decrease with age in both humans and in
animals who make their own VitC. An analysis of the ascorbic acid levels in the hepatic
cells of 24-26 month old rats showed a 68% decrease from the levels seen in 3-5 month
old rats157. Similarly in humans it has been known for several decades that serum
levels of VitC decrease with age. A meta-analysis of 30 publications showed a
significantly lower serum plasma VitC level older adults (aged 60-96) than in younger
adults (aged 15-65) with similar VitC intake156. The exact reason for this disparity is not
yet known however one study demonstrated that in older rats there was a 45%
decrease in the mRNA levels of one of the isoforms of the sodium dependent VitC
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transporter (SVCT1)157. Furthermore there are multiple studies which suggest that the
decrease in VitC associated with aging promote the development of chronic obstructive
pulmonary disease158,159. All of this research suggests that elderly people have both
higher VitC requirements than the young and a greater susceptibility to lung and injury
are related illnesses because of decreased VitC levels.
There are also experiments that demonstrate that levels of VitC that far exceed
those found in human and murine plasma and tissues can have a therapeutic effect. In
one experiment fibroblasts derived from human skin biopsies were cultured separated in
groups that were passaged 5, 10, 15, 20, 25 or 30 times respectively160. Cells that were
passage 20 or more times showed a significant loss of all enzyme activities. The
addition of ascorbate to the cell media equivalent to that of normal human plasma
concentrations (100 µmol 1−1) had no effect on the enzyme activities of the fibroblasts.
The addition of 300 µmol 1−1 ascorbate however totally restored Complex II-IV and
citrate synthase activities and partially restored the activity of Complexes I-III.
VitC has also been shown recently to be a powerful regulator of sepsis across
several experimental models and of sepsis induced ALI. Sepsis is a leading cause of
death in the United States and is the most common cause of death among critically ill
patients outside of coronary intensive care units161. The respiratory tract is the most
common site of septicemic infection and is associated with the highest
mortality. Patients who develop severe sepsis have a 25% in hospital mortality rate
which jumps to 50% in the case of septic shock. The incidence of severe sepsis in the
United States is estimated to be 300 cases per 100,000 population and septicemia
related hospital costs are estimated at $14 annually. MODS is the leading cause of
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death in sepsis patients and consequently the number of organs failing and the degree
of organ dysfunction is the leading predictor pf patient mortality109. Additionally,
septicemia incidence and septicemia-related deaths have increased over the past 2
decades in United States.
It is also known that a significant percentage of patients with severe sepsis
develop acute lung injury (ALI)162. Thus inducing sepsis is frequently used in in vivo
animal models to experimentally induce ALI. Sepsis is known to compromise alveolar
barrier integrity in a number of ways stemming from its associated systemic pro
inflammatory responses and the degradation of endothelial tight cell junctions 163. The
immune inflammatory response to the initial onset of sepsis is activation and tissue
infiltration of polymorphonuclear neutrophils PMNs. In the microenvironment of the
alveolus PMNs upregulate inflammation, increase the permeability of microvascular
barriers, and promote in extravascular accumulation of protein-rich edema fluid.
Alveolar infiltration of PMN is a hallmark of ALI and is known to be a primary
mechanism for sepsis-induced pulmonary dysfunction and injury154,164,165.
This PMN infiltration and the general inflammatory pathway that lead sepsis to
promote ALI is strongly regulated by NFkB. NFkB is proinflammatory transcription
factor that plays a key role in host defense, inflammation, and apoptosis 164,165. NFkB is
activated by proinflammatory cytokine induced phosphorylation and degradation of
inhibitor kB proteins. And TNFa induced NFkB activation has been shown to be
inhabitable with VitC in multiple studies and over multiple cell population.
Sepsis is also associated with a profound systemic oxidative stress which not
surprisingly has been demonstrated to severely lower antioxidant level in patient plasma
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including AscA. Therefore not surprisingly low levels of AscA correlate with multiple
organ system failure and inversely with patient survival154. It has also already been
shown experimentally that in VitC deficient animal models of sepsis that parenteral
ascorbate attenuates the effects of sepsis154,166. Experiments have also shown that in
WT mice administered parenteral VitC treatments have a strong therapeutic effect on
sepsis induced ALI.
Sepsis is modeled in a variety of ways in vivo. Endotoxin, a component of the
outer membrane of Gram-negative bacteria, is involved in the pathogenesis of sepsis,
and an LPS infusion/injection model has been widely used for sepsis research. LPS
administration induces systemic inflammation that mimics many of the initial clinical
features of sepsis, including increases in proinflammatory cytokines such as TNF-α and
IL-1, but without bacteremia167.
Sepsis also has a powerful interaction with patient age. Sepsis is the tenth
leading cause of death in patients over the age of 65 in the US since. Advanced aged
patients also account for 58–65% of all sepsis patients. Additionally, both the incidence
and mortality rates of sepsis patients increase significantly with advanced age 168
Owing to the fact that inhibition of LPS induced NFkB activation had not yet been
investigated, our collaborators conducted an in vivo study of VitC treatment on LPS
induced sepsis and ALI. ALI was induced in WT mice with an injection of a lethal
lipopolysaccharide (LPS) dose (10 ug/g of body weight). 30 minutes after the LPS
injection mice either received an intraperitoneal (i.p.) injection of 200 mg/kg AscA, the
oxidized form of AscA (DHA) at 200 mg/kg, or saline. There was a 100% mortality after
28 hours for mice receiving saline. In contrast there was a 60% survival for mice
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receiving AscA and a 75% survival rate for mice receiving DHA even after 72 hours. In
addition compared to saline controls, WT mice treated with AscA/DHA had suppressed
inflammatory chemokine expression, decreased microvascular thrombosis in the lungs,
suppressed proinflammatory gene expression, and attenuated neutrophilic capillaritis
and vascular leak in the lungs.
Another common method for modeling sepsis is through injection of fecal solution
known as fecal-induced peritonitis (FIP). Conventional animal models of sepsis are
typically microbial-based responses which may be mono- or poly-microbial in design.
Using a single organism results in a septic state that is dependent on the type and
amount used as well as the animal and route of administration, whereas a polymicrobial
model typically mimics intra-abdominal sepsis, which affects 20% of patients admitted
with sepsis. Polymicrobial models of sepsis typically involve either FIP or cecal ligation
and puncture (CLP). In the FIP model, a freshly prepared fecal solution is derived from
murine colonic stool and injected intraperitoneally into mice at a defined concentration
to result in acute peritonitis163,169.
Additionally, the same research group performed experiments directly tested the
effects of VitC deficiency on sepsis induced ALI in mice with and without VitC treatment.
Sepsis was induced with an i.p. injection of fecal stem solution which induced peritonitis
(FIP). They showed that the pathogenic effects of sepsis induced ALI were strongly
attenuated in VitC sufficient gulo-/- mice (gulo-/- supplemented with dietary VitC) and in
VitC deficient gulo-/- mice treated 30 minutes after FIP exposure with 200 mg/kg AscA
compared to their VitC deficient gulo-/- counterparts that received only saline treatment.
Gulo-/- mice who had either VitC supplementation or VitC treatment had less
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proinflammatory response in the lung, greater capillary barrier function in the lung, less
lung water accumulation, and better preservation of their lung architecture than mice
without any VitC treatment and the mice with both VitC supplementation and VitC
treatment had the greatest attenuation of sepsis induced ALI 154.
In addition to its usefulness in experimentally inducing ALI, sepsis bears a close
resemblance to the disease process of VILI. Experiments employing gene array
methodology to measure lung gene expression have identified differential patterns of
gene expression in animal models of VILI which are similar to those gene pathways
activated during experimental and clinical sepsis170,171. All of this has lead our group to
hypothesize that VitC treatments would confer a protective effect against ventilator
induced lung injury to our older mouse subjects.
Just as with LPS induced ALI, we hypothesize that VitC treatment’s down
regulation of NFkB, decrease of alveolar barrier permeability, and restoration of alveolar
barrier integrity will attenuate VILI induced edema in our aged mice. And based on the
wide spread protective effect that our novel low fluid protocol conferred we hypothesis
that VitC attenuation of edema will decrease injury and inflammation, improve
pulmonary mechanics, and increase subject survival. To test this hypothesis we
ventilated old mice old mice each either receiving VitC treatment or sham. During
ventilation we measured pulmonary mechanics. After ventilation treatments each
mouse was sacrificed and lung we to dry ratios were measured.
4.2.0 Methods
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4.2.1 Animal Use: This study was approved by the VCU Institutional Animal Care and
Use Committee (protocol number AD10000465). Male C57BL6 mice were used in
these experiments. All animal experiments were carried out under IACUC University
guidelines.
4.2.2 Age Groups: Old animals, 20-22 months of age, weighing 35 ± 11 g. Ages of
our murine subjects were based on correlations between murine lifespan and known
age-associated morphological changes in murine lung (17)(29).
4.2.3 Mechanical Ventilation: 20 month old Murine subjects were anesthetized and
mechanically ventilated for 1 hour using the same protocols outlined in chapter 2
methods section.
4.2.4 VitC Treatment: Each VitC treatment mouse received an IP injection of 200
mg/kg AscA in 100ul saline immediately prior to ventilation. Control mice received a
VitC sham IP injection of 100ul saline just prior to ventilation.
4.2.5 Pulmonary Mechanics: Pulmonary mechanics measurements were taken for
each subject at the 0hr and 1hr time points using the same protocol described in
chapter 2 methods.
4.2.6 Lung Wet to Dry Rations: After 1hr each subject was sacrificed, its lungs were
removed, and wet to dry ratios were collected using methods described in chapter 2
methods.
4.2.7 Data Analysis: Data analysis was performed on the pulmonary mechanics and
wet to dry ratio data using the same methods outlined in the chapter two methods
section.
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4.3.0 Results
4.3.1 One Hour Lung Wet to Dry Ratios: Wet to dry ratios for each of the old 1hr
groups (figure 38). The wet to dry ratios for HVT high fluid subjects receiving VitC
protocol was significantly lower than that observed in all other old groups (figure 38).
The wet to dry ratio of old HVT subjects receiving low fluid protocol was significantly
lower than that observed in the old HVT subjects who received high fluid protocol and
the old non-ventilated group (figure 38).

Figure 38: 1Hr Lung Wet to Dry Ratios. The Old HVT-HF-LF and Old HVT-HF-VitC groups were
significantly lower than that of Old non-ventilated and Old HVT-HF groups. Data are presented as mean
+/- st.dev N = 3, *p<0.05

4.3.2 PV Loop Hysteresis: PV loops were generated hourly using the Flexivent
software (Scireq) for each surviving subject. Representative PV loops shown in figure
39. The hysteresis values of each group were normalized with respective 0hr values
(figure 39). 1Hr PV loop hysteresis of Old HVT high fluid group was significantly greater
than that of the Old HVT low fluid and Old HTV high fluid VitC group (figure 39).
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Figure 39: 1Hr PV Loop Hysteresis. Hysteresis in the Old HVT-LF and Old HVT-HF-VitC group were
significantly greater than Old HVT HF. Data are presented as mean +/- st.dev N=3, *p<0.05

Figure 40: 1Hr Lung Compliance. Lung Compliance in the Old HVT-LF group was significantly
lower than Old HVT-HF. Data are presented as mean +/- st.dev N=3, *p<0.05

4.3.3 Lung Compliance: Lung compliance was measured hourly using the Flexivent
software (Scireq) for each surviving animal subject (figure 40). The 1Hr lung
compliance of the old HVT high fluid group was significantly greater than that of the
HVT low fluid group. There was a strong non-significant trend with the old 14Hr HVT
high fluid VitC group having a lower mean than the old 4Hr high fluid group that fell just
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short of significance. This HTC VitC has no significant differences with the HTV-LF
values with a one way anova P-value of .08. However, due to the need to exclude one
data outlier the groups has an N value of only N= 2. We suspect this relationship will
become significant with additional subjects.
4.4.0 Discussion
The only ventilation mechanics statistic that was collected but yielded no significance
was the measurement of inspiratory capacity. The low fluid treatment was able to
create a treatment based difference in the inspiratory capacity but it is possible that one
hour is simply insufficient for the VitC treatments to remodel this aspect of the
pulmonary mechanics.
The success of these early results is highly promising and offers a potentially
powerful therapeutic option for patients requiring mechanical ventilation. Considering
the natural decrease in VitC levels associated with age and the corresponding increase
in the severity of VILI seen with increasing patient age this development of age based
VitC treatments protocols for patients requiring mechanical ventilation may be critically
important for ensuring the health and wellbeing of elderly patients.
5.0.0
Implications of completed work
Close to a million patients in the US require mechanical ventilation annually. Knowing
that proper mechanical ventilation can literally mean the difference between life and
death for many of these patients means that the importance of mechanical ventilation
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cannot be overstated. Additionally, for a patient population this large, a 30% in hospital
mortality rate is devastating. However, the historical perspective on this mortality rate is
very elucidating as well. As recently as the 1970’s the in hospital mortality rate of
patients with severe ARDS was 90%172. And there are still particularly vulnerable
patient populations today. For example patients requiring MV as a result of ischemic
stroke have a short term mortality rate of 50-90% 173. In fact many of the most common
comorbidities with mechanical ventilation (ARDS, Phenomena, COPD, etc.) are known
to increase ventilator-associated mortality rates.
This reinforces the urgency with which we must not only drive down the overall
ventilator-associated patient mortality rates, but also identify populations particularly
sensitive to VILI and tailor specific treatments for them. Demographically the largest
sub population of ventilator patients with a significantly increased risk of mortality is the
elderly. In fact, patients over the age of 65 represent over half of all mechanically
ventilated patients. Furthermore the aging population in the US is poised to
precipitously grow over the next few decades174 which will only see an increases in the
urgency with which we must address this issue. While some of the mechanical changes
of the lung associated with aging have been studied and understood for the better part
of the last century, aging on the cellular level has only recently been studied.
Our initial four hour injurious mechanical ventilation protocol, while readily
survivable by young mice, proved to be too challenging for our older subjects with very
few surviving. In searching for protocol modifications that would aid elderly subject
survival we discovered a recent research consensus and resultant recommendation
from ARDSNet concerning the protective effects of fluid restriction. Critically ill ARDS
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patients with conservative fluid management had consistently better outcomes than
those treated with liberal fluid protocols. We hypothesized that a conservative fluid
protocol might confer protection to our aging VILI subjects as well.
Despite our hypothesis, our level of success at increasing the survival of our
older subjects by simply changing their fluid treatment protocol was more dramatic than
we had originally anticipated. A careful examination of the presence of pulmonary
edema as well as other markers of inflammation and injury clearly indicated that our
conservative fluid protocol alone was capable modulating VILI-associated edema.
Furthermore it established that resolution of this edema has a strong protective effect on
other downstream ventilator induced injuries.
Pulmonary edema is well established as a hallmark of VILI and is considered to
be a downstream inevitability of the type lung damage and inflammation there in. What
is so unique about this research is its establishment that pulmonary edema is actually
upstream of much of the injury and inflammation associated and VILI and that the
resolution of edema alone can dramatically increase the survival of elderly murine
subjects.
The implication of the research for elderly ventilator patients is both dramatic and
immediate. However, just as with all biomedical challenges it is important to pursue
multiple vectors of attack. Identifying pulmonary edema as a target in the ageassociated increase in ventilator-associated mortality opens the door for us to both seek
a more mechanistic explanation of these underlying processes and to pursue additional
treatment targets.
Moving forward, we had to attempt to answer the question as to why the lungs of
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our young subjects were so readily able clear or even avoid the accumulation addition 17
al of alveolar fluid load but this challenge proved fatal for our older subjects. The
answer to this question begins with the fulfilment of our second specific aim. Our
understanding of the aging lung epithelium as a physiological unit is radically
underdeveloped. Currently there are no major physiological mechanisms of the aging
alveolar epithelium itself that have been identified as major contributors to VILI.
Inflammation itself however, especially the presence of inflammatory cytokines, is
known to severely compromise epithelial barrier integrity and in the micro environment
of the lung strongly promoted edema. Furthermore there has been a recent explosion
in the understanding of the role of biotrauma as a mechanism of VILI. Furthermore, ER
stress is known to play a key role in many organ systems and pathological disease
states to promote age associate increases in inflammation. We hypothesized that ER
stress was likely a key player in the age-associated increase in VILI as well.
Knowing that stretch induced inflammation and injury can be achieved in cultured
primary alveolar epithelial cells, we hypothesized that cells harvested from old mice
would be significantly more injured/inflamed than young. Furthermore if our hypotheses
were correct, we would be able to attenuate this age-associated increase in
inflammation with the administration of an ER stress inhibitor. Our success at achieving
this result validates out hypothesis and establishes the importance of ER stress in the
age-associated increase in alveolar epithelial inflammatory response to mechanical
stretch. To establish the effect of this relationship on the development VILI-associated
edema in vivo experiments are clearly needed and represent an obvious avenue for
future research.
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The success of both of our first aims direct us to further expand our search for
treatments that might further fortify the alveolar epithelial barrier against insult and
injury. Our first aim identifies pulmonary edema as an important mechanism for the
age-associated increase VILI mortality rates in our subjects. Inflammation is known to
be a powerful promoter of alveolar edema and the completion of our second aim offers
a possible age-associated inflammatory mechanism driving our VILI-associated edema.
So an ideal preventative treatment for VILI would be one that was profoundly antiinflammatory, was known to decrease alveolar permeability, and had already been
proven to dramatically decrease pulmonary edema. VitC is well knows to be antiinflammatory, to decrease alveolar membrane permeability, and VitC treatments have
been shown to aide in the resolution of pulmonary edema. Additionally, VitC has
already been shown to have a dramatic effect on both ARDS and Sepsis. This is also
particular value in a potential VILI treatment owing to the fact that these diseases more
than any others either mimic or are direct pro/antecedent to VILI.
We naturally hypothesized that VitC would confer a protective effect to our older
murine subjects and attenuate their VILI-associated edema and the downstream
injurious effects. Our pilot study confirmed just this by showing a dramatic decrease in
the wet to dry ratios of old subjects treated with VitC prior to HVT mechanical
ventilation. Furthermore, impaired pulmonary mechanics which were identified in our
first project to be a downstream effect of VILI-associated edema were attenuated as
well. These preliminary results provide a strong proof of concept that VitC treatments
can attenuate the age-associated increase in VILI-associated edema. The next
experimental step is clearly outlined and will consist of a repeating our previous survival
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study with the addition of VitC treated subjects.
Each of these aims contributes indispensably to the picture of how the aging lung
interacts with VILI. The repositioning of pulmonary edema as a “mid-stream”
mechanism in VILI for the first time opens up anti-edema measures as a powerful
protective therapeutic target. Additionally, the identification of ER stress as a
regulatable source of age-associated stretch induced alveolar epithelial inflammation
makes the ER an invaluable target for attenuating age-associated pulmonary edema.
And finally the success that VitC has already enjoyed as a treatment for ARDS and
sepsis in mice combined without our pilot data demonstrating its ability to attenuate
VILI-associated edema starkly confirm the need for its pursuance as a preventative
treatment for VILI.
Our sincerest hope is that all three of these experimental avenues both
independently and in consort will push forward the development of much needed
lifesaving age dependent ventilator protocols in clinic.

109

References
1.

McNulty, W. & Usmani, O. S. Techniques of assessing small airways dysfunction. Eur.

2.

Kerr, J. B. Functional Histology. (Elsevier Mosby Australia, 2010).

4.

Sherwood, L. & Sherwood, L. Human physiology : from cells to systems. (Australia ; United

3.

5.

Clin. Respir. J. 1, (2014).

File:Alveolus diagram.svg. Wikipedia, the free encyclopedia
States : Brooks/Cole, Cengage Learning, 2010).

Weibel, E. R. Morphological basis of alveolar-capillary gas exchange. Physiol. Rev. 53,
419–495 (1973).

6.

Toshima, M. Three-dimensional architecture of elastin and collagen fiber networks in the

7.

Hicks, G. H. & Hicks, G. H. Cardiopulmonary anatomy and physiology. (Philadelphia : W.B.

human and rat lung. Arch. Histol. Cytol. 67, 31 (2004).
Saunders, 2000).

8.

Meyer, K. C., Ershler, W., Rosenthal, N. S., Lu, X. G. & Peterson, K. Immune dysregulation

9.

Lumb, A. B. Nunn’s applied respiratory physiology. (Edinburgh : Churchill Livingstone;

in the aging human lung. Am. J. Respir. Crit. Care Med. 153, 1072–1079 (1996).
Askews and Holts, 2010).

10. Cotes, J. E., Chinn, D. J. & Miller, M. R. Lung Function: Physiology, Measurement and
Application in Medicine. (Wiley, 2009).
11. Rogers, D. F. Physiology of airway mucus secretion and pathophysiology of

hypersecretion. Respir. Care 52, 1134–1146; discussion 1146–1149 (2007).

12. ROGERS, D. F. & ROGERS, D. F. AIRWAY GOBLET CELLS - RESPONSIVE AND
ADAPTABLE FRONT-LINE DEFENDERS. 7,

110

13. Ochs, M. et al. The number of alveoli in the human lung. Am. J. Respir. Crit. Care Med.
169, 120

14. Antrantik. The Respiratory System. Antranik.org Available at: http://antranik.org/therespiratory-system/. (Accessed: 11th August 2016)

15. Crandall, E. D., M., Crandall, E. D. & Matthay, M. A. Alveolar epithelial transport. Basic
science to clinical medicine. Am. J. Respir. Crit. Care Med. 163, 1021

16. Flodby, P. et al. Knockout Mice Reveal a Major Role for Alveolar Epithelial Type I Cells in
Alveolar Fluid Clearance. Am. J. Respir. Cell Mol. Biol. (2016). doi:10.1165/rcmb.20160005OC
17. Wong, M. H. & Johnson, M. D. Differential Response of Primary Alveolar Type I and Type
II Cells to LPS Stimulation. PLOS ONE 8, e55545 (2013).

18. Berthiaume, Y., Voisin, G. & Dagenais, A. The alveolar type I cells: the new knight of the
alveolus? J. Physiol. 572, 609–610 (2006).

19. Meyer, K. & Meyer, K. Lung Surfactants: Basic Science and Clinical Applications. Crit.
Care Med. 30, 266

20. Roan, E. & Waters, C. M. What do we know about mechanical strain in lung alveoli? Am. J.
Physiol. Lung Cell. Mol. Physiol. 301, L625–635 (2011).

21. Vaccaro, C. A., B., Vaccaro, C. A. & Brody, J. S. Structural features of alveolar wall
basement membrane in the adult rat lung. J. Cell Biol. 91, 427

22. Rubins, J. B. Alveolar macrophages: wielding the double-edged sword of inflammation.
Am. J. Respir. Crit. Care Med. 167, 103–104 (2003).

23. Alveolar macrophage seeking E. coli. Available at:
http://www.denniskunkel.com/detail/180.html. (Accessed: 11th August 2016)
24. Cotes, J. E. & Cotes, J. E. Lung function : physiology, measurement and application in
medicine. (Malden, Mass. ; Oxford : Blackwell Pub, 2006).
111

25. Harris, R. S. Pressure-volume curves of the respiratory system. Respir. Care 50, 78–98;
discussion 98–99 (2005).
26. Gattinoni, L. et al. Physical and biological triggers of ventilator-induced lung injury and its
prevention. Eur. Respir. J. 22, 15s–25s (2003).

27. Gattinoni, L., Protti, A., Caironi, P. & Carlesso, E. Ventilator-induced lung injury: the
anatomical and physiological framework. Crit. Care Med. 38, S539–548 (2010).

28. Plötz, F. B., Slutsky, A. S., van Vught, A. J. & Heijnen, C. J. Ventilator-induced lung injury
and multiple system organ failure: a critical review of facts and hypotheses. Intensive Care
Med. 30, 1865–1872 (2004).

29. Wunsch, H. et al. The epidemiology of mechanical ventilation use in the United States.
Crit. Care Med. 38, 1947–1953 (2010).

30. Slutsky, A. S. & Ranieri, V. M. Ventilator- induced lung injury. N. Engl. J. Med. 369, 2126
(2013).
31. Carrasco Loza, R., Villamizar Rodríguez, G. & Medel Fernández, N. Ventilator-Induced
Lung Injury (VILI) in Acute Respiratory Distress Syndrome (ARDS): Volutrauma and
Molecular Effects. Open Respir. Med. J. 9, 112–119 (2015).

32. Pesau, B. et al. Influence of age on outcome of mechanically ventilated patients in an
intensive care unit. Crit. Care Med. 20, 489–492 (1992).

33. Burr, M. L., Phillips, K. M. & Hurst, D. N. Lung function in the elderly. Thorax 40, 54–59
(1985).
34. Janssens, J.-P. Aging of the Respiratory System: Impact on Pulmonary Function Tests and
Adaptation to Exertion. Clin. Chest Med. 26, 469–484 (2005).

35. Dreyfuss, D., Soler, P., Basset, G. & Saumon, G. High Inflation Pressure Pulmonary
Edema: Respective Effects of High Airway Pressure, High Tidal Volume, and Positive Endexpiratory Pressure. Am. Rev. Respir. Dis. 137, 1159–1164 (1988).

112

36. Plötz, F. B. et al. Mechanical ventilation alters the immune response in children without
lung pathology. Intensive Care Med. 28, 486–492 (2002).

37. Kotecha, S. et al. The role of neutrophil apoptosis in the resolution of acute lung injury in
newborn infants. Thorax 58, 961 (2003).

38. Pugin, J. et al. Activation of human macrophages by mechanical ventilation in vitro. Am. J.
Physiol. - Lung Cell. Mol. Physiol. 275, L1040–L1050 (1998).

39. Lukkarinen, H. P., Laine, J. & Kääpä, P. O. Lung epithelial cells undergo apoptosis in
neonatal respiratory distress syndrome. Pediatr. Res. 53, 254–259 (2003).

40. Hammerschmidt, S. et al. Mechanical stretch alters alveolar type II cell mediator release
toward a proinflammatory pattern. Am. J. Respir. Cell Mol. Biol. 33, 203–210 (2005).

41. Halbertsma, F. J. J., Vaneker, M., Scheffer, G. J. & van der Hoeven, J. G. Cytokines and
biotrauma in ventilator-induced lung injury: a critical review of the literature. Neth. J. Med.
63, 382–392 (2005).

42. Douzinas, E. E. et al. The regional production of cytokines and lactate in sepsis-related
multiple organ failure. Am. J. Respir. Crit. Care Med. 155, 53–59 (1997).

43. Whitehead, T. C., Zhang, H., Mullen, B. & Slutsky, A. S. Effect of mechanical ventilation on
cytokine response to intratracheal lipopolysaccharide. Anesthesiology 101, 52–58 (2004).

44. Imai, Y. et al. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and
organ dysfunction in an experimental model of acute respiratory distress syndrome. JAMA
J. Am. Med. Assoc. 289, 2104 (2003).

45. The Acute Respiratory Distress Syndrome. Ventilation with lower tidal volumes as

compared with traditional tidal volumes for acute lung injury and the acute respiratory
distress syndrome. The Acute Respiratory Distress Syndrome Network. N. Engl. J. Med.
342, 1301–1308 (2000).

113

46. Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for

Acute Lung Injury and the Acute Respiratory Distress Syndrome. Surv. Anesthesiol. 45,
19–20 (2001).

47. Corti, M., Brody, A. R. & Harrison, J. H. Isolation and primary culture of murine alveolar
type II cells. Am. J. Respir. Cell Mol. Biol. 14, 309–315 (1996).

48. Matthay, M. A., Folkesson, H. G. & Clerici, C. Lung epithelial fluid transport and the
resolution of pulmonary edema. Physiol. Rev. 82, 569 (2002).

49. Lemyze, M. & Mallat, J. Understanding negative pressure pulmonary edema. Intensive
Care Med. 40, 1140–1143 (2014).

50. Matthay, M. A. Resolution of pulmonary edema. Thirty years of progress. Am. J. Respir.
Crit. Care Med. 189, 1301–1308 (2014).

51. Zhang, Z. & Chen, L. The association between fluid balance and mortality in patients with
ARDS was modified by serum potassium levels: a retrospective study. PeerJ 3, e752
(2015).
52. Edoute, Y., Roguin, A., Behar, D. & Reisner, S. A. Prospective evaluation of pulmonary
edema. Crit. Care Med. 28, 330 (2000).

53. de Prost, N., Ricard, J.-D., Saumon, G. & Dreyfuss, D. Ventilator-induced lung injury:
historical perspectives and clinical implications. Ann. Intensive Care 1, 1–15 (2011).

54. Capaldo, C. T. & Nusrat, A. Cytokine regulation of tight junctions. BBA - Biomembr. 1788,
864–871 (2009).

55. Baudouin, S. Ventilator induced lung injury and infection in the critically ill. Thorax 56, ii50–
ii57 (2001).
56. Putensen, C., Theuerkauf, N., Zinserling, J., Wrigge, H. & Pelosi, P. Meta-analysis:
ventilation strategies and outcomes of the acute respiratory distress syndrome and acute
lung injury. Ann. Intern. Med. 151, 566–576 (2009).

114

57. Paxson, J. A. et al. Age-dependent decline in mouse lung regeneration with loss of lung

fibroblast clonogenicity and increased myofibroblastic differentiation. PloS One 6, e23232
(2011).

58. Janssens, J. P., Pache, J. C. & Nicod, L. P. Physiological changes in respiratory function
associated with ageing. Eur. Respir. J. 13, 197 (9901).

59. Setzer, F. et al. Susceptibility to ventilator induced lung injury is increased in senescent
rats. Crit. Care 17, R99 (2013).

60. Zhang, Y.-W. et al. Reduced lung water transport rate associated with downregulation of
aquaporin-1 and aquaporin-5 in aged mice. Clin. Exp. Pharmacol. Physiol. 36, 734–738
(2009).

61. Zuurbier, C. J., Emons, V. M. & Ince, C. Hemodynamics of anesthetized ventilated mouse
models: aspects of anesthetics, fluid support, and strain. Am. J. Physiol. Heart Circ.
Physiol. 282, H2099–2105 (2002).

62. Anfinsen, C. B. The formation and stabilization of protein structure. Biochem. J. 128, 737–
749 (1972).

63. Alberts, B. et al. The Shape and Structure of Proteins. (2002).
64. Alberts, B. et al. The Endoplasmic Reticulum. (2002).
65. Braakman, I. & Hebert, D. N. Protein Folding in the Endoplasmic Reticulum. Cold Spring
Harb. Perspect. Biol. 5, a013201 (2013).

66. Dobson, C. M. Protein folding and misfolding. Nature 426, 884–890 (2003).
67. Reynaud, E. Protein Misfolding and Degenerative Diseases. Nat. Educ. 28

68. Zhou, H.-X. Influence of crowded cellular environments on protein folding, binding, and
oligomerization: Biological consequences and potentials of atomistic modeling. FEBS Lett.
587, 1053–1061 (2013).

69. Scheuner, D. et al. Control of mRNA translation preserves endoplasmic reticulum function
in beta cells and maintains glucose homeostasis. Nat. Med. 11, 757–764 (2005).

115

70. Ma, Y. & Hendershot, L. M. ER chaperone functions during normal and stress conditions.
J. Chem. Neuroanat. 28, 51–65 (2004).

71. Araki, K. & Nagata, K. Protein Folding and Quality Control in the ER. Cold Spring Harb.
Perspect. Biol. 3, (2011).

72. Brown, M. K. & Naidoo, N. The endoplasmic reticulum stress response in aging and agerelated diseases. Front. Physiol. 3, (2012).

73. Bravo, R. et al. Endoplasmic Reticulum and the Unfolded Protein Response: Dynamics
and Metabolic Integration. Int. Rev. Cell Mol. Biol. 301, 215–290 (2013).

74. Oslowski, C. M. & Urano, F. Measuring ER stress and the unfolded protein response using
mammalian tissue culture system. Methods Enzymol. 490, 71–92 (2011).

75. Harding, H. P., Zhang, Y., Bertolotti, A., Zeng, H. & Ron, D. Perk is essential for

translational regulation and cell survival during the unfolded protein response. Mol. Cell 5,
897–904 (2000).

76. Avivar-Valderas, A. et al. PERK integrates autophagy and oxidative stress responses to
promote survival during extracellular matrix detachment. Mol. Cell. Biol. 31, 3616–3629
(2011).
77. Yan, H., Wang, H., Zhang, X., Li, X. & Yu, J. Ascorbic acid ameliorates oxidative stress
and inflammation in dextran sulfate sodium-induced ulcerative colitis in mice. Int. J. Clin.
Exp. Med. 8, 20245–20253 (2015).

78. Chiang, W.-C., Hiramatsu, N., Messah, C., Kroeger, H. & Lin, J. H. Selective Activation of
ATF6 and PERK Endoplasmic Reticulum Stress Signaling Pathways Prevent Mutant
Rhodopsin Accumulation. Invest. Ophthalmol. Vis. Sci. 53, 7159–7166 (2012).

79. Hetz, C. The unfolded protein response: controlling cell fate decisions under ER stress and
beyond. Nat. Rev. Mol. Cell Biol. 13, 89–102 (2012).

80. Lindholm, D., Wootz, H. & Korhonen, L. ER stress and neurodegenerative diseases. Cell
Death Differ. 13, 385–392 (2006).

116

81. Paz Gavilán, M. et al. Cellular environment facilitates protein accumulation in aged rat
hippocampus. Neurobiol. Aging 27, 973–982 (2006).

82. Nuss, J. E., Choksi, K. B., DeFord, J. H. & Papaconstantinou, J. Decreased enzyme
activities of chaperones PDI and BiP in aged mouse livers. Biochem. Biophys. Res.
Commun. 365, 355–361 (2008).

83. Takeda, N. et al. Altered unfolded protein response is implicated in the age-related

exacerbation of proteinuria-induced proximal tubular cell damage. Am. J. Pathol. 183, 774–
785 (2013).

84. Andrade, P. V. et al. Influence of Hyperoxia and Mechanical Ventilation in Lung

Inflammation and Diaphragm Function in Aged Versus Adult Rats. Inflammation 37, 486–
494 (2013).

85. Caironi, P., Langer, T., Carlesso, E., Protti, A. & Gattinoni, L. Time to generate ventilatorinduced lung injury among mammals with healthy lungs: a unifying hypothesis. Intensive
Care Med. 37, 1913–1920 (2011).

86. Crane, S. D. Epidemiology, treatment and outcome of acidotic, acute, cardiogenic

pulmonary oedema presenting to an emergency department. Eur. J. Emerg. Med. Off. J.
Eur. Soc. Emerg. Med. 9, 320–324 (2002).

87. Chioncel, O. et al. Epidemiology, pathophysiology, and in-hospital management of
pulmonary edema: data from the Romanian Acute Heart Failure Syndromes registry. J.
Cardiovasc. Med. Hagerstown Md (2014). doi:10.2459/JCM.0000000000000192
88. Matthew W. Semler, Art P. Wheeler, Gordon R. Bernard, B. T. Thompson & Todd W. Rice.

in C95. WHAT’S NEW IN ACUTE RESPIRATORY DISTRESS SYNDROME A5094–A5094
(American Thoracic Society, 2014).

89. Pedreira, P. R. et al. Effects of melatonin in an experimental model of ventilator-induced
lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295, L820–827 (2008).

117

90. Eckle, T., Grenz, A., Laucher, S. & Eltzschig, H. K. A2B adenosine receptor signaling
attenuates acute lung injury by enhancing alveolar fluid clearance in mice. J. Clin. Invest.
118, 3301–3315 (2008).

91. Wilson, M. R., Patel, B. V. & Takata, M. Ventilation with ‘clinically-relevant’ high tidal

volumes does not promote stretch-induced injury in the lungs of healthy mice. Crit. Care
Med. 40, 2850–2857 (2012).

92. Wolthuis, E. K. et al. Mechanical ventilation using non-injurious ventilation settings causes
lung injury in the absence of pre-existing lung injury in healthy mice. Crit. Care Lond. Engl.
13, R1 (2009).

93. Wu, Y., Kharge, A. B. & Perlman, C. E. Lung ventilation injures areas with discrete alveolar
flooding, in a surface tension-dependent fashion. J. Appl. Physiol. Bethesda Md 1985 117,
788–796 (2014).
94. Chamorro-Marín, V., García-Delgado, M., Touma-Fernández, A., Aguilar-Alonso, E. &
Fernández-Mondejar, E. Intratracheal dopamine attenuates pulmonary edema and

improves survival after ventilator-induced lung injury in rats. Crit. Care Lond. Engl. 12, R39
(2008).
95. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS)
Clinical Trials Network et al. Comparison of two fluid-management strategies in acute lung
injury. N. Engl. J. Med. 354, 2564–2575 (2006).

96. Valentine, S. L. et al. Fluid balance in critically ill children with acute lung injury. Crit. Care
Med. 40, 2883–2889 (2012).

97. Murray, J. F. Pulmonary edema: pathophysiology and diagnosis. Int. J. Tuberc. Lung Dis.
Off. J. Int. Union Tuberc. Lung Dis. 15, 155–160, i (2011).

98. Tsukimoto, K. et al. Protein, cell, and LTB4 concentrations of lung edema fluid produced by
high capillary pressures in rabbit. J. Appl. Physiol. Bethesda Md 1985 76, 321–327 (1994).

118

99. Grinnan, D. C. & Truwit, J. D. Clinical review: Respiratory mechanics in spontaneous and
assisted ventilation. Crit. Care 9, 472–484 (2005).

100. Fahlman, A. et al. Inflation and deflation pressure-volume loops in anesthetized pinnipeds
confirms compliant chest and lungs. Front. Physiol. 5, (2014).

101. Biehl, M., Kashiouris, M. G. & Gajic, O. Ventilator-induced lung injury: minimizing its impact
in patients with or at risk for ARDS. Respir. Care 58, 927–937 (2013).

102. Sharma, G. & Goodwin, J. Effect of aging on respiratory system physiology and
immunology. Clin. Interv. Aging 1, 253–260 (2006).

103. Papandrinopoulou, D., Tzouda, V. & Tsoukalas, G. Lung Compliance and Chronic
Obstructive Pulmonary Disease. Pulm. Med. 2012, e542769 (2012).

104. Huang, K., Rabold, R., Schofield, B., Mitzner, W. & Tankersley, C. G. Age-dependent

changes of airway and lung parenchyma in C57BL/6J mice. J. Appl. Physiol. 102, 200–206
(2007).

105. Muñoz-Barrutia, A., Ceresa, M., Artaechevarria, X., Montuenga, L. M. & Ortiz-deSolorzano, C. Quantification of lung damage in an elastase-induced mouse model of
emphysema. Int. J. Biomed. Imaging 2012, 734734 (2012).

106. Loring, S. H. et al. Maintaining end-expiratory transpulmonary pressure prevents
worsening of ventilator-induced lung injury caused by chest wall constriction in surfactantdepleted rats. Crit. Care Med. 38, 2358–2364 (2010).

107. Interstitial lung disease. (Shelton, Conn. : People’s Medical Pub. House, 2011).
108. Elder, A. C., Finkelstein, J., Johnston, C., Gelein, R. & Oberdörster, G. Induction of

adaptation to inhaled lipopolysaccharide in young and old rats and mice. Inhal. Toxicol. 12,
225–243 (2000).

109. Systemic Inflammatory Response Syndrome: Background, Pathophysiology, Etiology.
(2016).
119

110. Jia, L.-X. et al. Mechanical stretch-induced endoplasmic reticulum stress, apoptosis and
inflammation contribute to thoracic aortic aneurysm and dissection. J. Pathol. 236, 373–
383 (2015).
111. Boudreault, F. & Tschumperlin, D. J. Stretch-induced mitogen-activated protein kinase

activation in lung fibroblasts is independent of receptor tyrosine kinases. Am. J. Respir.
Cell Mol. Biol. 43, 64–73 (2010).

112. Chatzigeorgiou, A. et al. The pattern of inflammatory/anti-inflammatory cytokines and
chemokines in type 1 diabetic patients over time. Ann. Med. 42, 426–438 (2010).

113. Davidovich, N. et al. Cyclic stretch-induced oxidative stress increases pulmonary alveolar
epithelial permeability. Am. J. Respir. Cell Mol. Biol. 49, 156–164 (2013).

114. Song, M. J., Davis, C. I., Lawrence, G. G. & Margulies, S. S. Local influence of cell viability
on stretch-induced permeability of alveolar epithelial cell monolayers. Cell. Mol. Bioeng. 9,
65–72 (2016).
115. Gao, J. et al. Preconditioning effects of physiological cyclic stretch on pathologically
mechanical stretch-induced alveolar epithelial cell apoptosis and barrier dysfunction.
Biochem. Biophys. Res. Commun. 448, 342–348 (2014).

116. Cohen, T. S., Cavanaugh, K. J. & Margulies, S. S. Frequency and peak stretch magnitude
affect alveolar epithelial permeability. Eur. Respir. J. 32, 854–861 (2008).

117. Heise, R. L., Stober, V., Cheluvaraju, C., Hollingsworth, J. W. & Garantziotis, S.
Mechanical Stretch Induces Epithelial-Mesenchymal Transition in Alveolar Epithelia via
Hyaluronan Activation of Innate Immunity. J. Biol. Chem. 286, 17435–17444 (2011).

118. Maciel-Barón, L. A. et al. Senescence associated secretory phenotype profile from primary
lung mice fibroblasts depends on the senescence induction stimuli. AGE 38, 1–14 (2016).

119. Kumar, M., Seeger, W. & Voswinckel, R. Senescence-Associated Secretory Phenotype
and Its Possible Role in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Cell Mol.
Biol. 51, 323–333 (2014).

120

120. Yin, L. et al. Aging exacerbates damage and delays repair of alveolar epithelia following
influenza viral pneumonia. Respir. Res. 15, 116 (2014).

121. Römisch, K. A cure for traffic jams: small molecule chaperones in the endoplasmic
reticulum. Traffic Cph. Den. 5, 815–820 (2004).

122. Schröder, M. & Kaufman, R. J. ER stress and the unfolded protein response. Mutat. Res.
569, 29–63 (2005).

123. Zhong, Q. et al. Role of Endoplasmic Reticulum Stress in Epithelial–Mesenchymal

Transition of Alveolar Epithelial Cells. Am. J. Respir. Cell Mol. Biol. 45, 498–509 (2011).

124. Naidoo, N. ER and aging—Protein folding and the ER stress response. Ageing Res. Rev.
8, 150–159 (2009).

125. Naidoo, N., Ferber, M., Master, M., Zhu, Y. & Pack, A. I. Aging impairs the unfolded protein
response to sleep deprivation and leads to proapoptotic signaling. J. Neurosci. Off. J. Soc.
Neurosci. 28, 6539–6548 (2008).

126. Hussain, S. G. & Ramaiah, K. V. A. Reduced eIF2alpha phosphorylation and increased

proapoptotic proteins in aging. Biochem. Biophys. Res. Commun. 355, 365–370 (2007).

127. Torres-González, E. et al. Role of Endoplasmic Reticulum Stress in Age-Related

Susceptibility to Lung Fibrosis. Am. J. Respir. Cell Mol. Biol. 46, 748–756 (2012).

128. Kim, H. J. et al. Inhibition of endoplasmic reticulum stress alleviates lipopolysaccharideinduced lung inflammation through modulation of NF-κB/HIF-1α signaling pathway. Sci.
Rep. 3, 1142 (2013).

129. Zhu, M., Guo, M., Fei, L., Pan, X.-Q. & Liu, Q.-Q. 4-phenylbutyric acid attenuates
endoplasmic reticulum stress-mediated pancreatic β-cell apoptosis in rats with
streptozotocin-induced diabetes. Endocrine 47, 129–137 (2014).

130. Slutsky, A. S. & Brochard, L. Mechanical Ventilation. (Springer Science & Business Media,
2006).
121

131. Brégeon, F. et al. Conventional mechanical ventilation of healthy lungs induced pro-

inflammatory cytokine gene transcription. Respir. Physiol. Neurobiol. 132, 191–203 (2002).

132. Ignatenko, O., Protsenko, D., Yaroshetskiy, A. & Gelfand, B. Conventional mechanical

ventilation can injury intact lungs in severe trauma patients. Crit. Care 14, P200 (2010).

133. Meier, T. et al. Pulmonary cytokine responses during mechanical ventilation of noninjured
lungs with and without end-expiratory pressure. Anesth. Analg. 107, 1265–1275 (2008).

134. Sutherasan, Y., Vargas, M. & Pelosi, P. Protective mechanical ventilation in the noninjured lung: review and meta-analysis. Crit. Care 18, 211 (2014).

135. Blázquez-Prieto, J. et al. Exposure to mechanical ventilation promotes tolerance to
ventilator-induced lung injury by Ccl3 downregulation. Am. J. Physiol. Lung Cell. Mol.
Physiol. 309, L847–856 (2015).

136. Ertugrul, A. S., Sahin, H., Dikilitas, A., Alpaslan, N. & Bozoglan, A. Evaluation of beta-2
microglobulin and alpha-2 macroglobulin levels in patients with different periodontal
diseases. Aust. Dent. J. 58, 170–175 (2013).

137. Liabeuf, S. et al. Plasma beta-2 microglobulin is associated with cardiovascular disease in
uremic patients. Kidney Int. 82, 1297–1303 (2012).

138. Lehmann, M. H. et al. CCL2 expression is mediated by type I IFN receptor and recruits NK
and T cells to the lung during MVA infection. J. Leukoc. Biol. 99, 1057–1064 (2016).

139. Kitamura, T. et al. CCL2-induced chemokine cascade promotes breast cancer metastasis
by enhancing retention of metastasis-associated macrophages. J. Exp. Med. 212, 1043–
1059 (2015).

140. Rose, C. E., Sung, S.-S. J. & Fu, S. M. Significant involvement of CCL2 (MCP-1) in
inflammatory disorders of the lung. Microcirc. N. Y. N 1994 10, 273–288 (2003).

141. Driscoll, K. E. Macrophage inflammatory proteins: biology and role in pulmonary
inflammation. Exp. Lung Res. 20, 473–490 (1994).

122

142. Chong, I.-W. et al. Expression and regulation of the macrophage inflammatory protein-1
alpha gene by nicotine in rat alveolar macrophages. Eur. Cytokine Netw. 13, 242–249
(2002).
143. Orjalo, A. V. et al. Cell Surface-Bound IL- 1Î± Is an Upstream Regulator of the

Senescence-Associated IL-6/ IL-8 Cytokine Network. Proc. Natl. Acad. Sci. U. S. A. 106,
17031–17036 (2009).

144. Suwara, M. I. et al. IL-1α released from damaged epithelial cells is sufficient and essential

to trigger inflammatory responses in human lung fibroblasts. Mucosal Immunol. 7, 684–693
(2014).

145. Ko, Y.-A., Yang, M.-C., Huang, H.-T., Hsu, C.-M. & Chen, L.-W. NF-κB activation in
myeloid cells mediates ventilator-induced lung injury. Respir. Res. 14, 69 (2013).

146. Krakauer, T. Nuclear factor-kappaB: fine-tuning a central integrator of diverse biologic
stimuli. Int. Rev. Immunol. 27, 286–292 (2008).

147. Culley, F. J. et al. Role of CCL5 (RANTES) in Viral Lung Disease. J. Virol. 80, 8151–8157
(2006).

148. Moran, C. J. et al. RANTES expression is a predictor of survival in stage I lung

adenocarcinoma. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 8, 3803–3812 (2002).

149. Pan, Z. Z., Parkyn, L., Ray, A. & Ray, P. Inducible lung-specific expression of RANTES:

preferential recruitment of neutrophils. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L658–
666 (2000).

150. Kuo, S.-M. The Multifaceted Biological Roles of VitC. J. Nutr. Food Sci. 03, (2013).
151. Figueroa-Méndez, R. & Rivas-Arancibia, S. VitC in Health and Disease: Its Role in the
Metabolism of Cells and Redox State in the Brain. Front. Physiol. 6, (2015).

152. Li, Y. et al. Restoration of VitC synthesis in transgenic Gulo-/- mice by helper-dependent

adenovirus-based expression of gulonolactone oxidase. Hum. Gene Ther. 19, 1349–1358
(2008).

123

153. Senmaru, T. et al. Pancreatic insulin release in VitC-deficient senescence marker protein30/gluconolactonase knockout mice. J. Clin. Biochem. Nutr. 50, 114–118 (2012).

154. Fisher, B. J. et al. Mechanisms of attenuation of abdominal sepsis induced acute lung
injury by ascorbic acid. Am. J. Physiol. Lung Cell. Mol. Physiol. 303, L20–32 (2012).

155. Li, W., Maeda, N. & Beck, M. A. VitC deficiency increases the lung pathology of influenza
virus-infected gulo-/- mice. J. Nutr. 136, 2611–2616 (2006).

156. Brubacher, D., Moser, U. & Jordan, P. VitC concentrations in plasma as a function of
intake: a meta-analysis. Int. J. Vitam. Nutr. Res. Int. Z. Für Vitam.- Ernährungsforschung J.
Int. Vitaminol. Nutr. 70, 226–237 (2000).

157. Michels, A. J., Joisher, N. & Hagen, T. M. Age-related decline of sodium-dependent

ascorbic acid transport in isolated rat hepatocytes. Arch. Biochem. Biophys. 410, 112–120
(2003).

158. Sargeant, L. A., Jaeckel, A. & Wareham, N. J. Interaction of VitC with the relation between
smoking and obstructive airways disease in EPIC Norfolk. European Prospective
Investigation into Cancer and Nutrition. Eur. Respir. J. 16, 397–403 (2000).

159. Siedlinski, M. et al. Lung function loss, smoking, VitC intake, and polymorphisms of the
glutamate-cysteine ligase genes. Am. J. Respir. Crit. Care Med. 178, 13–19 (2008).

160. Ghneim, H. K. & Al-Sheikh, Y. A. The effect of aging and increasing ascorbate
concentrations on respiratory chain activity in cultured human fibroblasts. Cell Biochem.
Funct. 28, 283–292 (2010).

161. Mayr, F. B., Yende, S. & Angus, D. C. Epidemiology of severe sepsis. Virulence 5, 4–11
(2014).
162. Sheu, C.-C. et al. Clinical Characteristics and Outcomes of Sepsis-Related vs Non-SepsisRelated ARDS. Chest 138, 559–567 (2010).

163. Nemzek, J. A., Hugunin, K. M. & Opp, M. R. Modeling Sepsis in the Laboratory: Merging
Sound Science with Animal Well-Being. Comp. Med. 58, 120–128 (2008).

124

164. Hoesel, L. M. et al. Harmful and protective roles of neutrophils in sepsis. Shock Augusta
Ga 24, 40–47 (2005).

165. Perl, M. et al. Role of activated neutrophils in chest trauma-induced septic acute lung
injury. Shock Augusta Ga 38, 98–106 (2012).

166. Fisher, B. J. et al. Attenuation of sepsis-induced organ injury in mice by VitC. JPEN J.
Parenter. Enteral Nutr. 38, 825–839 (2014).

167. Doi, K., Leelahavanichkul, A., Yuen, P. S. T. & Star, R. A. Animal models of sepsis and
sepsis-induced kidney injury. J. Clin. Invest. 119, 2868–2878 (2009).

168. Starr, M. E. & Saito, H. Sepsis in Old Age: Review of Human and Animal Studies. Aging
Dis. 5, 126–136 (2014).

169. Shrum, B. et al. A robust scoring system to evaluate sepsis severity in an animal model.
BMC Res. Notes 7, 233 (2014).

170. Dixon, D.-L. & Bersten, A. D. Sepsis and ventilator-induced lung injury: an imperfect storm.
Crit. Care Med. 41, 354–355 (2013).

171. Chacon-Cabrera, A. et al. Influence of mechanical ventilation and sepsis on redox balance
in diaphragm, myocardium, limb muscles, and lungs. Transl. Res. J. Lab. Clin. Med.
(2014). doi:10.1016/j.trsl.2014.07.003
172. de Prost, N., Ricard, J.-D., Saumon, G. & Dreyfuss, D. Ventilator-induced lung injury:
historical perspectives and clinical implications. Ann. Intensive Care 1, 28 (2011).

173. Golestanian, E., Liou, J.-I. & Smith, M. A. Long-Term Survival in Older Critically Ill Patients
with Acute Ischemic Stroke. Crit. Care Med. 37, 3107–3113 (2009).

174. Mather, M., Jacobsen, L. A. & Pollard, K. M. Aging in the United States. Popul. Bull. 70, 2–
18 (2015).

125

Vita

Joseph Ames Herbert was born on March 11th, 1983, in Auburn, Alabama, and is an
American citizen. He graduated from Franklin High School, Franklin, Virginia 2001. He
received a Bachelor’s of Science in Physics from the University of Mary Washington,
Fredericksburg, Virginia in 2005. He worked in the Radiation Oncology Laboratory of
Dr. Mark Dewhirst in Durham Virginia for 5 years.

126

